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 Breast cancer is the most prevalent type of cancer for women.  The American 
Cancer Society estimated that approximately 192,000 women were diagnosed with new 
cases of breast cancer in 2009.  Fortunately, the current five-year survival rate for early 
stage breast cancer is 98% (ACS, 2009).  This means many women diagnosed with breast 
cancer will become survivors.  Although transitioning from being a cancer patient to a 
cancer survivor may be a welcome milestone, it also comes with unpleasant side effects 
that can negatively impact quality of life (Allen, Savadatti, & Levy, 2009). 
 The primary purpose of this study was to examine the relationship among 
mindfulness, quality of life, alexithymia, and self-kindness in breast cancer survivors.  A 
total of 133 Stages 0 to III breast cancer survivors participated in the study.  Mindfulness, 
quality of life, self-kindness, and alexithymia were measured using the Five Facet 
Mindfulness Questionnaire, the Functional Assessment of Cancer Therapy-Breast, the 
Self-Compassion Scale, and the Toronto Alexithymia Scale.   
 A causal path analysis indicated that mindfulness was a significant predictor of 
quality of life, but self-kindness and alexithymia were not significant mediators.  Pearson 
Product Moment coefficients revealed significant relationships between the four study 
variables.  An ANOVA found that stage of cancer significantly impacted quality of life 
for Stage 0 and Stage III breast cancer survivors.  An ANOVA indicated no significant 
results for the type of surgery or time since completion of medical treatment on quality of 
life. 
 
 
 
 
 The results suggest that mindfulness, self-kindness, and alexithymia are important 
factors to consider for quality of life in Stage 0 to III breast cancer survivors.  Clinical 
implications exist for counselors.  Further research investigating possible moderating 
effects of self-kindness and alexithymia is needed.   
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CHAPTER I 
 
INTRODUCTION 
 
 
 In the United States, breast cancer is the most prevalent form of cancer for women 
with a 12.08% lifetime risk of developing breast cancer (American Cancer Society 
[ACS], 2009a).  In other words, approximately one out of every eight women in the U.S.  
will develop breast cancer over the course of her lifetime.  Further, incidences of breast 
cancer have been steadily increasing over the past thirty years.  An estimated 192,370 
women were diagnosed with new cases of breast cancer in 2009, representing an increase 
of nearly 14,000 new cases from the previous year (ACS, 2008).  While the incidence of 
breast cancer is increasing, fortunately the survival rate also is increasing.  The current 
five-year survival rates for localized breast cancer (i.e., cancer restricted to the breast) 
and regional breast cancer (i.e., cancer that may have spread to the lymph nodes or 
exterior breast tissues) is 98% and 84%, respectively (ACS, 2009a).  These numbers have 
improved since 2000, when the five-year survival rates for localized and regional breast 
cancers were 96% and 77%, respectively (ACS, 2001).  Five-year survival rates for 
women with advanced breast cancer (i.e., cancer that has spread to other parts of the 
body), however, are still low with 21% in 2000 and 23% in 2009 (ACS, 2001, 2009a).  
Nonetheless, the trends seem to be toward increased survival rates and, accordingly, it is 
important to direct research attention to breast cancer survivors.  In particular, it seems 
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vital to further study psychological issues among those diagnosed with an early stage 
disease as survival rates are particularly high for this group.   
 Transitioning from being a cancer patient to a cancer survivor may be a welcome 
milestone, but it also comes with unpleasant side effects that can negatively impact 
quality of life (Allen, Savadatti, & Levy, 2009).  Breast cancer survivors report 
experiencing a fear of disease recurrence, emotional distress, loss of structure and support 
that comes with medical appointments and being around other patients, and difficulty 
returning to life as it was before cancer (Allen et al., 2009).  Further, researchers have 
indicated that more than 50% of post-treatment breast cancer survivors suffer from 
fatigue and 20% struggle with depression (Broeckel, Jacobsen, Horton, Balducci, & 
Lyman, 1998; Burgess et al., 2005; Okuyama et al., 2000).  Some breast cancer survivors 
who underwent lymph node removal during their treatment surgeries or received high 
doses of radiation therapy are at risk of lymphedema, a painful arm, breast, and chest 
swelling condition that can restrict arm movement, impede physical activity, and affect 
quality of life (ACA, 2009a).  Further, side effects of medical treatments also have been 
found to cause challenges for breast cancer survivors, including treatment-induced 
menopause, body image concerns, and weight gain (Helms, O’Hea, & Corso, 2008).   
 The physical and emotional challenges that arise as a result of transitioning from 
active treatment to survivorship for women with breast cancer can be conceptualized 
through Transitions Theory.  Transitions Theory is a framework for conceptualizing 
major life changes such as diagnosis, treatment, and survivorship of breast cancer 
(Bridges, 1991).  Transitions Theory includes three stages (endings, neutral zones, and 
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beginnings).  Further, it holds that people must grieve the ending of one identity or life 
circumstance in order to resolve and apply meaning to the change as a way of creating 
and accepting a new identity and life circumstance.  This theory is a helpful lens in 
understanding how women transition from active breast cancer treatment to survivorship, 
particularly considering that women’s experiences with the disease may differ according 
to the staging of disease and the type of treatment.   
 The staging of breast cancer (i.e., the size of the original tumor and the spread of 
the disease), ranging from 0 to IV (0 is a less life threatening diagnosis and IV is the most 
life threatening diagnosis), appears to be an important distinction for breast cancer 
survivors and breast cancer researchers.  Given that the five year survival rate for stages 0 
to IV ranges from 100% (Stages 0 and I) to 86% (Stage II) to 57% (Stage III) to 23% 
(Stage IV), it is reasonable to categorize Stages 0 to II as early stage disease and stage IV 
as advanced stage disease (ACA, 2010).  Because stage III breast cancer survivors have 
more in common with those with earlier stages of disease (e.g., higher survival rate and 
less physical strain) than those with stage IV, many researchers distinguish between 
stages 0 to III as one group and stage IV as another group (Berger, Lockhart, & Agrawal, 
2009; Kim et al., 2008; Lengacher et al., 2009).  Further, some researchers have used 
stage 0 breast cancer survivors as a control group because the surgical treatment is 
minimally invasive compared to higher stages and these patients are less likely to receive 
adjuvant therapy (Castellon et al., 2004). 
Type of medical treatment also appears to impact the transition of breast cancer 
patient to breast cancer survivor.  It is standard practice for many breast cancer survivors, 
4 
 
 
particularly those diagnosed with Stage I-IV cancer, to receive some form of adjuvant 
therapy, including chemotherapy, radiation therapy, and hormone therapy, following 
surgical treatment.  It is important to understand that the side effects of these adjuvant 
therapies differ.  For example, chemotherapy has been found to impact fatigue, 
menopausal symptoms, and cognitive functioning more than hormone and radiation 
therapy (Mar Fan et al., 2005).  Furthermore, the amount of time since the completion of 
these treatments is important.  In a longitudinal study on the impact of adjuvant therapies 
on fatigue, menopausal symptoms, and cognitive functioning among breast cancer 
survivors, the adverse side effects improved over time (Mar Fan et al., 2005).  Therefore, 
it is important to consider the impact of the type of medical treatment received and the 
time since the completion of treatment when investigating the impact of adjuvant 
treatment on quality of life of breast cancer survivors.   
 Quality of life is a multi-dimensional construct that describes the level of one’s 
physical, social, functional, and emotional well-being, as well as one’s ability to enjoy 
life and experience meaning and purpose in life (Brady et al., 1997; Canada, Murphy, 
Fitchett, Peterman, & Shover, 2008).  Even when treatment for breast cancer ends and 
improvements are made in physical functioning, breast cancer survivors may continue to 
experience psychological distress (Pinto, Clark, Maruyama, & Feder, 2003).  Further, 
emotional distress may exacerbate fears of the future (Lebel, Rosberger, Edgar, & 
Devins, 2009).  For example, some breast cancer survivors rated fear of dying, fear of 
cancer recurrence, and fear of future treatment as more distressing than role disruption 
concerns and physical concerns (Vickberg, 2003).  Further, the inability to express this 
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emotional distress may play a role in overall health outcomes, including the level to 
which survivors experience threats to their quality of life (Nyklicek, Vingerhoets, & 
Denollet, 2002).  Difficulty identifying, expressing, and distinguishing between feelings 
or emotional arousal is referred to as alexithymia (Porcelli, Tulipani, Maiello, Cilenti, & 
Todarello, 2007).   
 The impact of alexithymia on quality of life among breast cancer survivors is 
unclear at this point.  Of the limited studies to date, most researchers have investigated 
alexithymia as either a diagnostic factor in breast cancer (Servaes, Vingerhoets, 
Vreugdenhil, Keuning, & Brockhuijsen, 1999) or a contributor to immunity suppression 
(Todarello, La Pesa, Zaka, Martino, & Lattanzio, 1989).  That is, researchers have 
focused primarily on how alexithymia influences the medical condition.  For example, in 
a study of 86 women with breast cancer, 36.4% revealed traits consistent with 
alexithymia (Manna et al., 2007).  In another study, researchers investigated the 
relationship between alexithymia and pain experience in a mixed group of cancer 
diagnoses and found that those who struggled to identify their feelings reported higher 
levels of pain (Porcelli et al., 2007).  Because researchers have focused on the impact of 
alexithymia on medical conditions and physical symptoms, what is unknown to date is 
the extent to which alexithymia is related to psychosocial quality of life among survivors.  
Researchers seem clear that alexithymia is a construct that is prevalent for women with 
breast cancer and that it appears to be related to medical and physical issues.  What is less 
clear, however, is how alexithymia may be related to post-treatment side-effects and 
overall quality of life.  It is viable that breast cancer survivors who are not able to identify 
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or express their emotions may experience increased difficulties as they move through the 
developmental transitions of survivorship.  
 Another construct that appears to be important for survivors is mindfulness.  
Mindfulness is defined as a nonjudgmental awareness of the present moment (Kabat-
Zinn, 1990).  Mindfulness means being able to pay attention to and identify bodily 
present moment experiences (Kieviet-Stijnen, Visser, Garssen, & Hudig, 2008).  
Recently, mindfulness researchers have begun to establish positive effects on 
psychological well-being, medical symptoms, and stress symptoms among those with 
stress-related illnesses, anxiety, cancer, and chronic pain (Baer, 2003; Carmody & Baer, 
2008).  Among cancer patients, those who completed mindfulness-based stress reduction 
training reported less stress, higher moods, and better quality of life than those in control 
groups (Baer, 2003; Kieviet-Stijnen et al., 2008).  Similarly, researchers have found that 
mindfulness training improved overall quality of life, sleep quality, and symptoms of 
stress among breast and prostate cancer patients (Carlson, Speca, Patel, & Goodey, 
2004).  Though it has been established that mindfulness can positively affect quality of 
life in various populations, little is known about the critical factors of mindfulness that 
contribute to the change.  In particular, researchers have not considered the possibility 
that the relationship between mindfulness and quality of life may be mediated by other 
factors, including alexithymia and self-kindness (Neff, 2003).   
 Self-kindness involves extending kindness and gentleness toward oneself and 
attempting to understand one’s self rather than engaging in self-judgment or criticism 
(Neff, 2003).  Though self-kindness has been an important aspect of Buddhist psychology 
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for over a thousand years, limited empirical research has been conducted (Kornfield, 
2009).  In fact, to date researchers have only investigated self-kindness as a component of 
self-compassion, rather than a unique construct (Neff, 2003).  Given the emphasis on 
wellness and positive development within counseling, it seems appropriate to investigate 
self-kindness.  In summary, then, mindfulness, alexithymia, and self-kindness all seem to 
have some influence on quality of life among cancer survivors.  It seems important, 
therefore, to pursue an understanding of the relationships between these factors within a 
multivariate framework.   
Statement of the Problem 
 There is a growing interest in mind-body medicine and alternative approaches to 
healing for cancer patients (Carlson et al., 2004; Cassileth & Chapman, 1998).  
Specifically, mindfulness training holds promise.  In fact, Mindfulness-Based Stress 
Reduction (MBSR; Kabat-Zinn, 1990) is one alternative approach that holds promise for 
cancer patients as well as cancer survivors.  For example, MBSR has been found to 
improve quality of life in early stage breast cancer patients (Carlson et al., 2004; Witek-
Janusek et al., 2008).  Researchers to date, however, have not investigated the 
relationship between mindfulness and quality of life among breast cancer survivors who 
have undergone recent adjuvant therapy that has included chemotherapy and few 
researchers have included participants who have undergone radiation therapy.  For 
example, Carlson et al. (2004) did not include breast cancer survivors who had completed 
chemotherapy, radiation, or hormone therapy within the prior three months for their study 
on mindfulness based stress reduction and quality of life.  Similarly, Witek-Janusek et al. 
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(2008) excluded breast cancer survivors who had undergone systemic chemotherapy.  
Secondly, researchers who have considered the relationship between mindfulness and 
quality of life have not focused solely on breast cancer survivors, but rather included 
mixed cancer diagnoses.  Because of this, little is known about the unique attributes of 
breast cancer survivors.  Finally, though there is strong empirical evidence for the 
positive impact of mindfulness on reducing negative emotions (e.g., anxiety), no studies 
have investigated the potential for mindfulness to increase positive emotional states such 
as self-kindness. 
 Self-kindness is a construct that focuses on being patient and tender with one’s 
self in the context of suffering (Neff, 2003).  Theoretically, mindfulness is a related but 
distinct construct from self-kindness (Neff, 2003).  Researchers to date, however, have 
provided no empirical evidence for this relationship.  Furthermore, researchers have not 
considered self-kindness among a population of breast cancer patients and, more 
specifically, have not investigated the relationship between self-kindness, mindfulness, 
and quality of life among breast cancer patients. 
 As a construct, alexithymia focuses on difficulty identifying and describing 
emotions (Taylor & Bagby, 2000).  Banner (2009) found that alexithymia was a strong 
predictor of anxiety in women with stages I to III breast cancer.  To date, however, no 
researchers have focused on the relationship between alexithymia and quality of life 
among breast cancer survivors.  Because breast cancer patients have been found to 
experience powerful emotions as a result of their diagnosis and struggle to experience 
and express these emotions in a healthy manner (Manna et al., 2007), it is important to 
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investigate how alexithymia mediates the relationship between mindfulness and quality 
of life among breast cancer patients (Kabat-Zinn, 1990; Witek-Janusek et al., 2008). 
Purpose of the Study 
 The purpose of this study, then, is to investigate the relationships among 
mindfulness, self-kindness, alexithymia, and quality of life in stages 0 to III breast cancer 
survivors.  A secondary purpose is to consider how type and time since completion of 
medical treatment affects quality of life within this group.  This study will contribute to 
the current body of research on breast cancer survivors and the factors that may improve 
their quality of life during the transition period from patient to survivor.  Further, this 
study will add to the current body of literature on self-kindness and mindfulness.  Results 
from this study will inform counselors, counselor educators, other mental health 
professionals, and medical professionals who specialize in the biopsychosocial concerns 
of oncology populations. 
Research Questions 
 The proposed study will investigate the relationships among mindfulness, 
alexithymia, self-compassion, and quality of life among female breast cancer survivors 
(stages 0 – III), and examine a hypothesized path model.  The following research 
questions will be addressed: 
Research Question 1: What is the effect of time since completion of treatment (in 
months) on mindfulness, alexithymia, self-kindness, and quality of life for female 
survivors of breast cancer (Stages 0-III) and the relationship among mindfulness, 
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alexithymia, self-kindness, and quality of life for female survivors of breast cancer 
(Stages 0-III)? 
Research Question 2: What are the effects of cancer stage (0-III) on mean scores of 
mindfulness, alexithymia, self-kindness, and quality of life among female survivors of 
breast cancer?  
Research Question 3: What are the effects of surgery (i.e., none, lumpectomy, or 
mastectomy) and adjuvant therapy (i.e., none, hormone therapy, chemotherapy, or 
radiation) on mean scores of mindfulness, alexithymia, self-kindness, and quality of life 
among female survivors of breast cancer?  
Research Question 4: What are the relationships among mindfulness, alexithymia, self-
compassion, and quality of life within a path model (see Figure 1) that specifies a 
relationship between mindfulness and quality of life mediated by alexithymia and self-
kindness? 
 
 
 
 
 
 
 
 
 
Figure 1.  Hypothesized Path Model 
 
Mindfulness 
Alexithymia 
Self-Kindness 
Quality of Life 
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Need for the Study 
 Breast cancer is the most common type of cancer for women in the United States.  
The American Cancer Society (ACS) estimated that there were 192,370 new cases of 
breast cancer in women in 2009 (ACS, 2009a).  Because of early disease diagnosis and 
advanced medical treatment, the five-year survival rate for localized stage breast cancer 
(i.e., stages 0 to II) is 98% and the five-year survival rate for all stages combined (i.e., 
stages 0 to IV) is 89% (ACS, 2009a).  While the survival rate is high, breast cancer 
patients still face physical and emotional challenges that can affect their quality of life.  
Regardless of cancer staging, a diagnosis of breast cancer has been found to elicit a high 
level of distress (National Cancer Institute, 2009).  This could explain, at least in part, 
why breast cancer patients are seeking alternative therapies, including mindfulness 
training, to cope with the emotional and physical strain of cancer (Cassileth & Chapman, 
1998).   
Although there is some initial evidence supporting the relationship between 
mindfulness and quality of life among cancer survivors (Carlson et al., 2004; Witek-
Janusek et al., 2008), researchers have not considered that there may be mediating factors 
that influence the relationship between mindfulness and quality of life.  Two possible 
mediating factors that show promise are alexithymia and self-kindness. 
Results of this study could increase counselors’ understanding of working with 
breast cancer survivors, including how to help them improve their quality of life and 
manage the side effects of medical treatment as they transition into survivorship.  Further, 
results will inform future intervention studies that target mindfulness, self-kindness, and 
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alexithymia among patients and, in turn, inform counselors in using interventions for 
breast cancer survivors that target mindfulness, self-kindness, and alexithymia.   
Results from this study also will contribute to the current body of literature on 
breast cancer survivorship and quality of life.  Specifically, results of this study will 
provide researchers and clinicians with a more thorough understanding of the role of 
mindfulness, self-kindness, and alexithymia in quality of life among breast cancer 
survivors.  Finally, this study may inform future longitudinal studies that could determine 
developmental stages of transition into survivorship and quality of life for breast cancer 
patients.   
Definition of Terms 
Quality of life is defined as a multi-dimensional, holistic “assessment of the 
combined impact of disease and treatment” on cancer survivors (Cella et al., 1993).  
Further, quality of life further is defined as optimal physical well-being, social well-
being, emotional well-being, and functional well-being during and after medical 
treatment for cancer (Cella et al., 1993).  For the purposes of this study, quality of life 
will be measured using the Functional Assessment of Cancer Therapy-Breast Quality of 
Life Instrument (FACT-B; Brady et al., 1997).  The FACT-B is a quality of life 
instrument that has six subscales: physical well-being, social/family well-being, 
relationship with doctor, emotional well-being, functional well-being, and additional 
concerns specific to breast cancer.   
Alexithymia is defined as emotional restriction that involves difficulty identifying 
and describing feelings, as well as an orientation toward external thinking (Bagby, 
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Parker, & Taylor, 1994).  In this study, alexithymia will be measured using the Toronto 
Alexithymia Scale (TAS-20; Bagby, Parker, et al., 1994). 
Mindfulness is defined as a nonjudgmental awareness of the present moment 
(Kieviet-Stijnen et al., 2008) and will be measured using the Five Facet Mindfulness 
Questionnaire (FFMQ; Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006).  The FFMQ 
has five scales that include (a) nonreactivity to inner experience, (b) 
observing/noticing/attending to sensations/perceptions/thoughts/feelings, (c) acting with 
awareness, (d) describing/labeling with words, and (e) nonjudging of experience (Baer et 
al., 2006). 
Self-kindness is defined as being open to one’s suffering and pain and having a 
sense of caring and kindness toward oneself, (Neff, 2003) as measured by the Self-
Compassion Scale (SCS, Neff, 2003). 
Stage 0 breast cancer is a diagnosis of breast cancer where the disease is 
considered non-invasive and localized to the original affected tissue area of the breast 
(ACA, 2009a). 
Stage I breast cancer is a diagnosis of breast cancer where the disease is invasive 
and the breast cancer cells are beginning to invade surrounding tissue area.  The tumor 
size for stage 1 breast cancer is up to two centimeters and lymph nodes are disease free 
(ACA, 2009a). 
Stage II breast cancer is a diagnosis of breast cancer where the tumor has either 
surpassed two centimeters or the disease has spread to the lymph nodes (ACA, 2009a). 
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Stage III breast cancer is a diagnosis of breast cancer where the tumor has either 
surpassed five centimeters or spread to the chest wall.  The disease may have spread to 
the lymph nodes as well.  Inflammatory breast cancer, a tumor-less breast cancer, is 
considered stage 3 (ACA, 2009a).   
Stage IV breast cancer is a diagnosis of breast cancer where the disease has 
spread to other areas of the body; usually the bones, brain, liver, or lungs.  This is an 
advanced cancer stage (ACA, 2009a).   
Localized breast cancer is defined as breast cancer that is restricted to the breast 
without evidence of spread to the lymph nodes or surrounding area (ACA, 2009a).   
Regional breast cancer is defined as cancer that is located within the breast and 
surrounding lymph nodes (ACA, 2009a). 
Advanced breast cancer is defined as cancer that has spread from the original site 
in the breast to other areas of the body.  This includes the spread of disease to lymph 
nodes, lungs, bones, brain, and liver.  When the disease has spread to distant parts of the 
body, the term metastatic breast cancer is used (ACA, 2009a). 
Five-year survival rate is defined as the percentage of women with breast cancer 
who are still living within a five-year period since the original diagnosis.  This definition 
includes breast cancer survivors who die from non-cancer-related causes (ACA, 2009a).   
Adjuvant therapy is defined as treatment used in addition to the primary source of 
treatment.  Examples of adjuvant therapies for breast cancer treatment include radiation 
therapy, chemotherapy, and hormone therapy.  The primary source of treatment for breast 
cancer typically is surgery (ACA, 2009a). 
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Radiation therapy is defined as treatment with high-energy rays (such as x-rays) 
to kill cancer cells and shrink tumors (ACA, 2010). 
Chemotherapy is defined as therapy for breast cancer that includes drugs used to 
weaken and kill cancer cells.  Chemotherapy may be administered through intravenous 
drips or pill form (ACA, 2009a). 
Hormone therapy is defined as treatment for breast cancer that includes the use of 
hormone drugs to alter hormone production.  For breast cancer treatment, hormone 
therapy typically is used to reduce production of estrogen (ACA, 2009a). 
Surgery is defined as breast cancer treatment that involves the removal of part or 
the entire breast.  A lumpectomy is a type of surgery that involves removing the tumor 
and part of the surrounding breast tissue.  This surgery is done for early stage breast 
cancer.  A mastectomy is a type of surgery that involves the removal of the breast and 
part or all of the surrounding tissue, including skin, nipple, areola, and lymph nodes.  
Mastectomies are performed on a case-by-case basis, though typically for more serious 
diagnoses, and may even be used as preventive medicine (ACA, 2009a).   
Brief Overview 
 This study will be organized over five chapters.  The first chapter includes a brief 
introduction to breast cancer and a preliminary examination of quality of life, 
alexithymia, mindfulness, and self-kindness as it pertains to breast cancer survivors.  The 
purpose of the study, statement of the problem, need for the study, definition of key 
terms, and a brief description of the study also are presented in the first chapter.  The 
second chapter includes a review and critique of the literature relevant to this research 
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study, including sections on breast cancer survivors, quality of life, transitions theory, 
alexithymia, mindfulness, and self-kindness.  The third chapter contains an overview of 
the methodology for this study, including a description of the participants, sampling 
methods, instruments, and data analyses.  The fourth chapter will provide a presentation 
of the results by addressing the five research questions.  Chapter five will include a 
summary of the relevant study results and implications for counselors and counselor 
educators.  Further, recommendations for future research and implications for counseling 
practice will be delineated.   
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CHAPTER II 
 
REVIEW OF RELATED LITERATURE 
 
 
 Cancer is a group of diseases in which abnormal cells in the body mutate and 
grow out of control (ACS, 2009a).  These cells become diseased due to DNA damage 
caused by genetics, lifestyle choices, and environmental influences (ACS, 2010).  Cancer 
accounts for approximately a quarter of all deaths in the United States, making it the 
second leading cause of death behind heart disease (ACS, 2008).  Because of advances in 
early detection and treatment, however, 66% of all cancer patients in the United States 
will live for five years or more (ACS, 2009b).  Of particular interest to the current study, 
the five year survival rate for localized breast cancer is 98% (ACS, 2009a).  This 
translates into over two million breast cancer survivors in the United States (ACS, 
2009a).   
The Biology of Breast Cancer 
 Breast cancer is a disease that originates from the cells of the breast (ACS, 2010).  
It typically forms in breast ducts, tubes that carry milk to the nipple, or lobules, glands 
that produce milk (ACS, 2010).  Cancer cells develop and spread to form tumors when 
old cells do not die or when there is an overgrowth of new cells (ACS, 2010).  These 
tumors can be harmless, non-cancerous tumors referred to as benign tumors or diseased, 
cancerous tumors called malignant tumors (ACS, 2010).  When cells from malignant 
tumors enter the bloodstream or lymphatic system the cancer can spread to other parts of 
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the body (ACS, 2010).  These new areas of cancer growth are referred to as metastases 
(ACS, 2010).  Physicians use the level of metastases and the size of the original tumor to 
determine the stage of breast cancer (ACS, 2010). 
Stage of Breast Cancer 
 Breast cancer stage refers to the gravity of the breast cancer diagnosis and is used 
to inform treatment plans (ACS, 2010).  Staging is determined in one of two ways: 
clinical staging and pathologic staging.  Clinical staging is used when the stage of the 
disease is determined based on the results of a physical exam, biopsy, or imaging test 
(ACS, 2010).  Pathologic staging is based on the results of surgery used to assess the 
breast tumor and surrounding lymph nodes (ACS, 2010.  Because pathological staging is 
considered more accurate, it is the preferred type of staging among medical professionals. 
 The American Joint Committee on Cancer (AJCC) developed a pathologic staging 
system referred to as the TNM system (ACS, 2010).  TNM staging classifies the level of 
breast disease based on their T, N, and M stage.  T stands for tumor (i.e., how big is the 
tumor), N stands for the spread of disease to lymph nodes (i.e., which lymph nodes are 
affected by the disease), and M stands for metastasis (i.e., has the disease spread to other 
areas of the body) (ACS, 2010).  Following the letters T, N, and M appears a number 
which provides additional information about the tumor, lymph nodes, and metastasis.  
The number following the T refers to the size of the tumor.  These numbers range from 0 
to 4 with four indicating a larger tumor size.  The number following the N indicates 
whether the cancer has spread to the lymph nodes.  This number ranges from 0 to 3 with 
3 indicating advanced spread to the lymph nodes.  The number following the M refers to 
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whether or not the disease has metastasized in the body.  The number for this marker is 
either a 0 (no cancer metastasis) or 1 (positive cancer metastasis) (ACS, 2010).   
 Once the TNM staging has been completed the cancer diagnosis is then stage 
grouped.  Stage grouping is used to inform medical treatment and ranges from I (least 
advanced) to IV (most advanced) cancer (ACS, 2010).  Stage 0 is considered non-
invasive and easily treatable (ACS, 2010).  Stage 0 is the earliest form of breast cancer 
and is used when the cancer is limited to the ducts and lobules with not spread to fatty 
breast tissue (ACS, 2010).  Stage IA indicates that the tumor size is 2 cm or less with no 
spread to the axillary lymph nodes or metastases.  Stage IB indicates the tumor is 2 cm or 
less with minimal metastases in one to three axillary lymph nodes.  Two conditions exist 
to meet criteria for Stage IIA: (a) the tumor is 2 cm or less and cancer larger than 2 mm 
has spread to 1 to 3 axillary lymph nodes, or (b) the tumor is greater than 2 cm and less 
than 5 cm with no spread to the axillary lymph nodes.  Stage IIB also has two conditions: 
(a) the tumor is larger than 2 cm but less than 5 cm and has spread to 1 to 3 axillary 
lymph nodes, or (b) the tumor is larger than 5 cm but has not spread to the axillary lymph 
nodes or invaded the chest walls.  Two conditions apply to Stage IIIA: (a) the tumor is 
less than 5 cm but has spread to 4 to 9 axillary lymph nodes; or (b) the tumor is greater 
than 5 cm, has spread to 1 to 9 axillary lymph nodes, but has not grown into the chest 
wall.  Three conditions apply to Stage IIIB.  The tumor has grown into the chest wall and 
one of the following are present: (a) no spread to the axillary lymph, (b) spread to 1 to 3 
axillary lymph nodes with trace amount of cancer found in the internal mammary lymph 
nodes, or (c) spread to 4 to 9 axillary lymph nodes or enlarged mammary lymph nodes.  
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For Stage IIIC, the tumor can be any size and one of the following conditions is present: 
(a) cancer has spread to 10 or more axillary lymph nodes, (b) cancer has spread to lymph 
nodes under the collar bone, (c) cancer has spread to lymph nodes above the collar bone, 
or (d) cancer has spread to 4 or more axillary lymph nodes and mammary lymph nodes.  
Stage IV is the most advanced breast cancer diagnosis and is used to refer to any breast 
cancer that has spread to the bone, liver, brain, or lung (ACS, 2010).   
All of the staging information is used to determine the type of treatment for breast 
cancer.  The majority of breast cancer cases are diagnosed in the early stages (ACS, 
2010), resulting in increased prevalence, treatability, and survivorship. 
Prevalence of Cancer 
 Breast cancer is the most common form of cancer for women (excluding skin 
cancer, which is not included in general cancer statistics because it is a unique form of 
cancer) (ACS, 2010).  The American Cancer Society reported 192, 370 new cases of 
breast cancer in 2009 (ACS, 2010).  Both men and women can develop breast cancer but 
it is 100 times more likely to occur in women due to the effects of the female hormones 
estrogen and progesterone (ACS, 2010).  There are many risk factors for breast cancer, 
some which women cannot change, including gender, age (risk increases with age), 
heredity, gene mutations, family and personal history of breast cancer, density of breast 
tissue, early menses (before age 12), and race (Caucasians have the highest risk) (ACS, 
2010).  Additional lifestyle risk factors include use of oral contraceptives (birth control), 
hormone replacement therapy, not having children or having children after age 30, not 
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breast feeding, alcohol use (higher usage increases risk), being overweight, and lack of 
physical activity (ACS, 2010). 
 The current five-year survival rate for localized breast cancer (i.e., cancer 
restricted to the breast) is 98% and 84% for regional breast cancer (i.e., cancer that has 
spread to the lymph nodes or exterior breast tissues) (ACS, 2009a).  The prevalence of 
breast cancer indicates that many women are impacted by breast cancer and the survival 
rates indicate that attention must be given to survivorship.   
Survivorship 
As of January 1, 2007, an estimated 2.5 million breast cancer survivors were 
living in the United States (Altekruse et al., 2010).  Survivors have unique needs that are 
beginning to be addressed (ACS, 2010; Morgan, 2009).  As a result, the National Cancer 
Institute (NCI) established the Office of Cancer Survivorship whose primary function is 
to support research on preventing or reducing the negative effects of cancer on quality of 
life.  Often, women experience difficult transitions beginning at the point of cancer 
diagnosis and may experience physical and emotional challenges post-surgery, a time 
period often referred to as the re-entry phase (Allen et al., 2009).  Though researchers are 
beginning to learn more about this transition, further knowledge is needed on breast 
cancer survivorship, including the impact on quality of life, in order to promote overall 
well-being.  That is, given the high rates of survivorship and the serious emotional and 
physical sequelae of breast cancer, it is important to increase our understanding of the 
effects of diagnosis, surgery, and treatment on quality of life. 
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Treatment of Breast Cancer 
 There are two broad types of treatment for breast cancer: local therapy and 
systemic therapy (ACS, 2010).  Local therapy, such as surgery and radiation, are limited 
to one specific area of the body (ACS, 2010).  Conversely, systemic therapy such as 
chemotherapy and hormone therapy are delivered into the bloodstream so that they can 
treat cancer cells throughout the entire body (ACS, 2010).  Often, systemic therapy is 
used following surgery, given the possibility that cancer cells may have broken off from 
the breast tumor and traveled through the bloodstream into other areas of the body (ACS, 
2010). 
Surgical Treatment for Breast Cancer 
 Most breast cancer survivors have had some type of surgery to remove the breast 
tumor.  Each surgery option has unique benefits and challenges, making surgery selection 
a personal and, oftentimes, difficult decision (ACS, 2010).  The two main categories of 
surgical treatment for breast cancer are breast-conserving surgeries and mastectomies 
(ACS, 2010). 
 Breast-conserving surgeries.  Breast-conserving surgeries are surgeries that 
involve removing part of the breast.  This includes lumpectomies and partial 
mastectomies (ACS, 2010).  A lumpectomy removes only the breast tumor and marginal 
healthy breast tissue (ACS, 2010).  A partial mastectomy removes more breast tissue than 
a lumpectomy.  Typically, at least one quarter of the breast is removed in partial 
mastectomies (ACS, 2010).   
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 Side effects for breast-conserving surgeries include temporary pain and swelling, 
pain, and hard scar tissue development (ACS, 2010).  Additionally, a risk for bleeding 
and infection at the surgery site exists (ACS, 2010).  Among women who have lymph 
nodes removed during their surgeries, lymphedema can develop.  Lymphedema occurs 
when lymph fluid is retained in the arm, causing debilitating swelling and pain (ACS, 
2009a).  
 Mastectomies.  Mastectomies are surgeries that remove the entire breast (ACS, 
2010).  There are two primary types of mastectomies, simple mastectomy and radical 
mastectomy.  In a simple mastectomy the entire breast is removed, including the nipple 
(ACS, 2010).  A radical mastectomy is more invasive in that the breast, nipple, underarm 
lymph nodes, and chest muscle tissues are removed (ACS, 2010).  Because this surgery is 
extensive, it typically is limited to women with large tumors that have grown into the 
pectoral muscles under the breast (ACS, 2010).   
 Side-effects for mastectomies include obvious changes to the breast and surgical 
related pain (ACS, 2010).  They also include possible risk of infection, hematoma 
(buildup of blood in the wound), seroma (buildup of fluid in the wound), numbness in the 
upper and inner arm, limited arm movement (frozen shoulder), and lymphedema (ACS, 
2010).   
 Regardless of the type of surgery, it is clear that women will experience intense 
physical effects from surgery for breast cancer.  Twenty to 60 percent of women who 
undergo these surgeries will develop post-mastectomy pain syndrome (this includes 
women who underwent a lumpectomy) (ACS, 2010).  Post-mastectomy pain syndrome 
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includes chest wall pain, tingling down the arm, pain in the shoulder, scar, arm, and 
armpit, numbness and shooting pain, and oppressive itching (ACS, 2010).  Along with 
the physical sequelae of breast cancer surgery, women may experience additional 
concerns that can impact quality of life as a result of post-surgery adjuvant therapy. 
Adjuvant Therapies for Breast Cancer 
 Adjuvant therapies for breast cancer are treatments that occur after the primary 
treatment (surgery).  The most common adjuvant therapies for early-stage breast cancer 
are radiation, chemotherapy, and hormone therapy (ACS, 2010). 
 Radiation.  Radiation therapy is targeted treatment that utilizes high-energy rays 
directed at the breast, chest wall, or underarm region following surgery (ACS, 2010).  
The purpose of radiation is to kill remaining cancer cells that may still be harbored in the 
body, despite surgical removal of the diseased part of the breast.  The amount of radiation 
prescribed to a woman varies depending on the type of surgery and the spread of the 
disease (ACS, 2010).  A typical radiation prescription is five days per week for six weeks 
(ASC, 2010).  The side-effects of radiation can vary from moderate to severe.  Some 
women will experience swelling and heaviness of the breast, skin burns, and fatigue 
(ACS, 2010).  More severe symptoms include breast reconstruction complications, 
lymphedema, rib fractures, and, in rare cases, development of new cancer (ACS, 2010).  
Most of the mild symptoms alleviate after 6 to 12 months, while the more severe 
symptoms may be permanent (ACS, 2010). 
 Chemotherapy.  Chemotherapy is a systemic treatment that introduces cancer 
killing drugs into the bloodstream (to travel throughout the body) intravenously and 
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orally (ACS, 2010).  The goal of chemotherapy is to attack and destroy leftover cancer 
cells from surgery.  Chemotherapy is typically administered in cycles (e.g., on two 
weeks, off two weeks) and lasts for several months (ACS, 2010).  Though treatment 
plans vary, chemotherapy usually is most effective when multiple drugs are used 
simultaneously (ACS, 2010).  Because chemotherapy is a powerful adjuvant therapy that 
works by killing cells that divide and spread into cancer cells, sometimes healthy cells are 
destroyed in the process.  Though each woman’s experience is unique, common side-
effects resulting from the destruction of healthy cells exist include hair loss, nausea and 
vomiting, loss of appetite, mouth sores, risk of infection, easy bruising, and fatigue (ACS, 
2010).  All of these side-effects subside when treatment ceases.  There are additional 
side-effects, however, that are long lasting or permanent.  Younger women who have not 
entered menopause may experience treatment induced menopause, which causes 
infertility, hot flashes, and fatigue (ACS, 2010).  Other risks include neuropathy (nerve 
damage) in the hands and feet, heart damage, an increased risk for leukemia, excessive 
fatigue, and a decrease in cognitive function that affects memory and concentration 
(“chemo brain”) (ACS, 2010). 
Hormone therapy.  Hormone therapy is a systemic form of adjuvant therapy that 
is used to prevent the recurrence and spread of breast cancer (ACS, 2010).  Because two 
out of three breast cancers are facilitated by estrogen, the hormone produced from a 
woman’s ovaries, drugs used to block the effects of estrogen or lower the estrogen level 
in the body are prescribed to prevent the growth or spread of breast cancer (ACS, 2010).  
Anti-estrogen drugs are prescribed in pill form and taken daily (ACS, 2010).  Side-effects 
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for these drugs include symptoms similar to menopause including hot flashes, vaginal 
dryness, fatigue, and mood swings (ACS, 2010).  Additional, more serious, side-effects 
include risk of endometrial and uterine cancer, heart attack, stroke, and pulmonary 
embolism (a blood clot in the lung) (ACS, 2010).   
 Improvements in treatment for breast cancer have helped to lead to a higher 
survivor rate.  It seems apparent, however, that the diagnosis, surgery, and adjuvant 
treatment of breast cancer remains a harrowing and life-altering experience.  
Accordingly, the transition into survivorship can include difficult quality of life issues. 
Quality of Life Effects from Breast Cancer 
 In order to support and care for breast cancer survivors, it is important to 
understand relevant quality of life issues.  Quality of life is a multi-dimensional construct 
that includes broad areas related to physical well-being (e.g., level of energy), social 
well-being (e.g., feeling close to friends and family), emotional well-being (e.g., having 
hope), functional well-being (e.g., ability to work), and concerns specific to breast cancer 
(e.g., feelings of femininity and self-consciousness) (Brady et al., 1997).   
 The most powerful predictor of quality of life is a survivor’s perception of control 
(Ferrell, Dow, & Grant, 1995).  Additionally, there are a number of physical issues that 
impact quality of life, including physical pain and fatigue (Ferrell et al., 1995).  Pain and 
fatigue have been found to be strong predictors of quality of life and are common side-
effects of breast cancer treatment (ACS, 2010; Ferrell et al., 1995).  Additional physical 
outcomes of breast cancer survivorship include an altered body image, cardiac damage, 
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sexual dysfunction, osteoporosis (bone loss), nerve damage, premature menopause, and 
secondary cancers (Morgan, 2009).   
 Psychological issues also affect quality of life.  For many breast cancer survivors, 
fear of disease recurrence is an ongoing dilemma (Ferrell et al., 1995).  Furthermore, 
many survivors worry that they may be passing along to their children a genetic 
predisposition to cancer.  Others may suffer from cognitive changes (i.e., memory loss), 
financial concerns, body image concerns, and altered femininity (Brady et al., 1997; 
Morgan, 2009).  Many of these physical and psychological concerns that affect quality of 
life are direct effects of the cancer diagnosis, treatment, and transition into survivorship 
(ACS, 2010). 
Quality of Life Effects of Diagnosis 
A breast cancer diagnosis can elicit clinically significant levels of traumatic stress 
symptoms, including symptoms of intrusion and avoidance.  In a study of 125 women 
diagnosed with metastatic breast cancer or a recurrence of cancer, over half scored in the 
high range on the Impact of Events Scale (Horowitz, Wilner, & Alvarez, 1979), 
indicating significant levels of distress (Butler, Koopman, Classen, & Spiegel, 1999).  
Similarly, 32.8% of breast cancer patients in a large sample (n = 1249) experienced 
depression, anxiety, and hostility related to their diagnosis (Zabora, Brintzenhofeszoc, 
Curbow, Hooker, & Plantadosi, 2001). 
Quality of Life Effects of Surgery  
 Efforts to improve quality of life in breast cancer survivors have led researchers to 
investigate the impact of surgery on women.  More specifically, researchers have begun 
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to investigate the impact of breast-conserving surgeries versus mastectomies on quality of 
life (Moyer, 1997).  Currently, treatment for early-stage breast cancer is treated with a 
mastectomy or breast-conserving surgery plus radiation (ACS, 2010; Moyer, 1997).  
Survival rates for both modes of treatment are equivalent, so the decision to undergo 
breast-conserving surgery or mastectomy is a personal decision that has possible 
implications on quality of life (Moyer, 1997).   
 Physical outcomes.  Researchers have found few treatment-related differences in 
quality of life for breast cancer survivors who have undergone breast-conserving surgery 
versus mastectomy (Ganz et al., 2004; Janni et al., 2001).  The primary differences that 
have been established include concerns about body image and sexuality (Janni et al., 
2001; Janz et al., 2005).  Though most researchers have found that breast conserving 
surgery results in fewer sexual problems and higher body image than mastectomies 
(Moyer, 1997; Rowland et al., 2000), one group of researchers found that breast-
conserving surgery led to lower levels of sexual functioning and sexual enjoyment 
compared to mastectomy plus breast reconstruction (Janz et al., 2005).  Consistent with 
previous findings, though, Janz et al. (2005) did find that women who had breast-
conserving surgery had higher body image, on average, than women who had a 
mastectomy.   
 Emotional outcomes.  In addition to physical quality of life concerns resulting 
from breast surgery, emotional concerns exist as well.  Women awaiting breast surgery 
have been found to have low emotional well-being, intrusive thoughts, and increased 
distress (Schnur et al., 2008).  In a study of 187 women scheduled for a diagnostic breast 
29 
 
 
biopsy or a curative lumpectomy (Schnur et al., 2008), a series of surveys measuring 
distress (Profile of Moods States; Shacham, 1983), emotional well-being (Emotional 
Well-Being Subscale of the Functional Assessment of Cancer Therapy-General; Webster, 
Cella, & Yost, 2003), intrusive thoughts (Intrusion Subscale of the Impact of Events 
Scale; Horowitz et al., 1979), and emotional upset (Visual Analog Scale Emotional 
Upset; Ahearn, 1997) were completed on the day of participants’ scheduled breast 
surgery.  Results indicated that women in both groups reported heightened levels of 
distress, though the lumpectomy group was significantly higher.  Further, women 
scheduled for a lumpectomy surgery reported significantly higher levels of emotional 
upset and intrusive thoughts and lower levels of emotional well-being compared to the 
diagnostic biopsy group.  It appears, therefore, that treatment-related surgery causes more 
anticipatory distress and upset than diagnostic procedures. 
Following breast surgery, it appears that women are likely to experience increased 
depressive symptoms.  For example, Karademas, Argyropoulou, and Karvelis (2007) 
compared women who had undergone mastectomies and were considered disease-free to 
a healthy control group.  A total of 103 breast cancer survivors and 100 matched controls 
completed a series of questionnaires, including the General Health Questionnaire 
(Moutzoukis, Adamopoulou, Garyfallos, & Karastergiou, 1990), the Ways of Coping 
Questionnaire (Folkman, Lazarus, Dunkel-Schetter, DeLongis, & Gruen, 1986), and an 
illness-related stress measure.  Results revealed that women in the mastectomy group 
reported significantly more depressive symptoms than the matched control group.  No 
group differences were found on other psychological scales (anxiety, somatic symptoms, 
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social dysfunction).  Because women included in the mastectomy group had been 
disease-free for more than three years and still reported higher levels of depressive 
symptoms, it seems evident that the emotional impact of breast cancer is lasting. 
In addition to experiencing symptoms of depression, breast cancer survivors are at 
risk for suffering symptoms of post-traumatic stress (Kornblith et al., 2003).  In a study 
on the long- term impact of breast cancer on survivors’ quality of life and symptoms of 
post-traumatic stress, 153 women aged 41 to 87 who had undergone mastectomies and 
adjuvant therapy within the past 15 to 23 years completed a series of questionnaires in a 
telephone interview.  Participants were asked to answer questions for the following 
assessments: the Brief Symptom Inventory (Derogatis & Melisaratos, 1983), 
Posttraumatic Stress Disorder Checklist (the trauma was identified as cancer; Weathers, 
Litz, Herman, Huska, & Keane, 1993), Conditioned Nausea, Vomiting, and Distress 
(Cella, Pratt, & Holland, 1986), European Organization for Research Treatment of 
Cancer Quality of Life (Aaronson et al., 1993), and Life Experience Survey (Sarason, 
Johnson, & Siegel, 1978), and the MOS Social Support Survey (Sherbourne & Stewart, 
1991).  Based on the Brief Symptom Inventory, 5% of survivors obtained scores 
indicative of a psychiatric disorder.  Also, it was noted that 15% of the survivors reported 
experiencing two or more symptoms of posttraumatic stress “extremely often.”  
Furthermore, nearly 5% of survivors met diagnostic criteria for posttraumatic stress 
disorder.  Those with lymphodema and numbness were at an even higher risk for 
experiencing symptoms of posttraumatic stress (Kornblith et al., 2003). 
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Decision regret related to the type of surgery chosen also is an emotional outcome 
related to quality of life for breast cancer survivors (Sheehan, Sherman, Lam, & Boyages, 
2008).  The period following diagnosis can be especially challenging.  Women must cope 
with the shock of learning they have breast cancer while making difficult and complex 
decisions related to medical treatment, including the decision on what type of surgery to 
have (breast-conserving versus mastectomy and reconstruction versus no-reconstruction 
(Sheehan et al., 2008).  In a study on psychosocial and surgical factors on decision regret 
among breast cancer survivors, decision regret was a relevant outcome related to breast 
cancer (Sheehan et al., 2008).  In their study, Sheehan et al. (2008) assessed 123 women 
(mean age 52) who had undergone immediate or delayed breast reconstruction following 
surgery.  Decision regret was measured using the Decision Regret Scale (Brehaut et al., 
2003), body image was measured using the Body Image Scale (Hopwood, Fletcher, Lee, 
& Al-Ghazal, 2001), distress was measured using the Impact of Event Scale (Horowitz et 
al., 1979), social support was measured with the Social Support Questionnaire (Sarason, 
Sarason, Shearin, & Pierce, 1987), mood was measured with the Positive and Negative 
Affect Schedule (Watson, Clark, & Tellegen, 1988), and decision influence was 
determined with a one-item question about the level of decision influence experienced 
with answer choices ranging from “it was totally my decision” to “it was totally my 
doctor’s decision.”  Results indicated that 27.6% of breast cancer survivors experienced 
mild regret and 19.5% experienced moderate to strong regret.  Decision regret was 
related to negative body image and increased psychological distress.  Based on their 
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findings, expectation of surgical outcomes has been hypothesized to alleviate decision 
regret (Sheehan et al., 2008). 
Additionally, fear of disease recurrence is a universal fear for breast cancer 
survivors that can cause significant distress and impact on quality of life.  Although it is 
known that most cancer survivors experience fear of disease recurrence, less is known 
about this fear during the transition from active patient to survivor.  Allen et al. (2009) 
qualitatively investigated the transition from breast cancer patient to survivor and the 
impact on fear of recurrence.  Focus group methodology was used for this study, 
including six groups of approximately 8 women per group.  Eligible participants included 
recent (within the past year) breast cancer survivors of Stage I and II cancer who had 
undergone adjuvant therapy.  Fear of disease recurrence was a powerful fear, with some 
women thinking about it daily.  Furthermore, emotional distress, including depression, 
was believed to be related to fear of recurrence.  Losses associated with the end of 
treatment (i.e., being monitored by medical staff and daily radiation appointments) were 
associated with fear.  It is understood that heightened fear can compromise quality of life 
by creating a hyper-vigilance of physical symptoms (Allen et al., 2009).   
Quality of Life Effects of Adjuvant Therapies 
 All adjuvant therapies (radiation, chemotherapy, hormone therapy) have the 
potential to affect quality of life in some way (ACS, 2010).  The areas most impacted by 
adjuvant treatment include physical health, psychological and emotional well-being, role 
functioning, social issues, and spousal intimacy (Feigin et al., 2000).  Furthermore, the 
quality of life impact from adjuvant therapies can last for years after treatment has ended 
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(Schover et al., 1995).  In particular, chemotherapy has been found to have a long-term 
impact on quality of life issues, including psychological distress, poor body image, sexual 
dysfunction (Schover et al., 1995) and declined mental health (Helgeson, Snyder, & 
Seltman, 2004) for up to four years after treatment.   
It is viable that the physical impact adjuvant therapies have on the body impacts 
the overall quality of life.  Also, higher levels of post-treatment fatigue have been 
associated with lower quality of life regardless of the intensity of the adjuvant regimen 
(Berger et al., 2009).  Adjuvant therapy, while medically necessary in many cases, further 
complicates the recovery process.  Women who receive adjuvant therapy post-surgery 
appear to experience more psychological distress and physical impairments than women 
who have surgery alone (Ganz et al., 2004). 
The cumulative side-effects of breast cancer treatment, adjuvant treatments, and 
unclear expectations of returning to “normal” once treatment has ended make 
transitioning from patient to survivor difficult.  How a woman transitions into 
survivorship, however, can greatly affect quality of life.  In fact, women who enter this 
“re-entry” phase with heightened distress have been found to have diminished long-term 
adjustments (Allen et al., 2009; Carver & Antoni, 2004).  Clearly, then, it is important to 
understand the impact of transitioning to survivorship on quality of life. 
Quality of Life Effects during the Transition to Survivorship 
 Breast cancer survivors experience varying phases of distress from their initial 
diagnosis to long-term survivor issues.  Henselman et al. (2010) identified four distress 
trajectories for breast cancer survivors including (a) the initial diagnosis, (b) active 
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treatment, (c) reentry to survivorship, and (d) chronic distress within survivorship.  
Though little is known about survivorship for women with breast cancer, researchers are 
starting to investigate the impact of the “re-entry phase” or, in other words, the transition 
to survivorship (Morgan, 2009; Rancour, 2008). 
 Transitioning from patient to survivor comes with a significant amount of 
uncertainty (Morgan, 2009).  Uncertainty related to the meaning of the breast cancer and 
the comprehensive impact of the disease is a primary concern for survivors once they end 
active treatment, let go of the routine structure and security of regularly scheduled 
medical appointments and communication with medical staff, and attempt to return to 
their daily lives (Morgan, 2009).  Because it is unlikely that a person can return to life 
exactly as it was before cancer, the NCI (2006) recommends survivors find a “new 
normal.”  In a sense, a new normal is a new identity, including new perceptions, 
behaviors, and ways of being in relationships.  Creating a new identity can be distressing 
and grieving the old identity and desire to return to life as it was may be necessary 
(Rancour, 2008).  Additional considerations survivors face that affect quality of life 
during this transition include decisions about follow-up care, creating wellness plans, 
managing physical changes, coping with body and intimacy changes, identifying and 
understanding feelings and emotions, and coping with family and workplace changes 
(NCI, 2006). 
 Decisions about follow-up care can be especially upsetting for survivors, given 
the uncertainty and fear of future outcomes including the possibility of disease recurrence 
(Allen et al., 2009).  Including survivors in the decision-making process for post-
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treatment follow-up care has been found to improve overall quality of life (Anderson & 
Urban, 1999).  In a study of 292 breast cancer survivors between the ages of 50 and 85, 
over half (52%) perceived that they had an active role in their follow-up treatment and 
80.4% reported satisfaction with their level of involvement (Anderson & Urban, 1999).  
Further, having an active role in the decision-making process for follow-up care was 
found to be a significant predictor of quality of life on six scales including, pain, general 
health, vitality, physical functioning, emotional functioning, and mental health (Anderson 
& Urban, 1999).  Having a high level of involvement in the treatment-related decision 
was not a significant predictor, however, of quality of life for active treatment (surgery 
and adjuvant therapy).  This suggests that having a level of control and active 
involvement may be most important during the transition into survivorship.   
 It is important to recognize that the end of cancer treatment does not signify the 
end of the impact of cancer on breast cancer survivors.  Many women continue to suffer 
psychological distress due to the perceived inescapability of a future disease threat and 
bodily changes (Deimling, Kahana, Bowman, & Schaefer, 2002; Gurevich, Devins, & 
Rodin, 2002; Sinding & Gray, 2005).  For example, in one study of cancer survivors who 
had completed treatment for breast, prostate, and colorectal cancers, 180 male and female 
survivors over the age of 60 were interviewed about their level of distress (Deimling et 
al., 2002).  Breast cancer survivors comprised 41% of this study population.  Results 
indicated that 25% of the population met clinical levels for depression, as measured by 
the CES-D (Radloff, 1977).  Additionally, 25% of the population endorsed significant 
levels of hyper-arousal and 30% endorsed difficult concentrating, as measured by PTSD 
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Checklist-Civilian (Weathers et al., 1993).  Survivors who had undergone chemotherapy, 
in addition to surgery or other adjuvant therapies, reported significantly higher levels of 
depression and hostility.  Similarly, Sinding and Gray (2005) interviewed 10 breast 
cancer survivors and highlighted a theme that cancer was ongoing even after the 
cessation of active treatment.  In the context of focus groups, breast cancer survivors 
spoke of residual anxiety, depression, and reminders of the disease.  In reference to the 
daily reminders of her surgical scars, one survivor lamented, “You can’t get up and get 
dressed without being reminded.”  In association with increased hyper-arousal and 
perceived future disease threat, another survivor spoke of “waiting for the other shoe to 
drop.”  From these research findings, it seems clear that the impact of cancer continues 
past the end of treatment.  These concerns can be understood within the framework of 
Transitions Theory (Bridges, 1991). 
Transitions Theory 
 Transitions Theory is a framework for navigating major life change (Bridges, 
1991).  Transitioning into survivorship is a major life change and can be a challenge for 
women with breast cancer.  Women may experience a disorienting void when they leave 
their safety net of medical personnel, routine hospital visits, and scheduled treatment plan 
(Rancour, 2008).  Because survivorship is the original goal, women may feel confused 
when they transition into survivorship and realize they are not the same person as when 
they started their cancer journey.  Many survivors expect for their lives and relationships 
to return to the way they were and to move forward in life, as if breast cancer was a 
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benign illness with no aftermath (Rancour, 2008).  Bridges’ (2004) Transitions Theory is 
a useful framework for the transition into survivorship. 
 Transitions Theory breaks down transitions into three distinct stages: endings, 
neutral zone, and beginnings (Bridges, 2004).  The first stage implies that transitions 
include leaving one way of being or leaving something that is familiar (Bridges, 1991).  
Even when the ending is a positive transition (completing cancer treatment), a sense of 
loss or grief may be present (Rancour, 2008).  Survivors may have unrealistic 
expectations of how quickly their physical, psychological, relational, and spiritual 
adjustments will occur once treatment ends (Rancour, 2008).  According to Transitions 
Theory, survivors in this stage may be disengaged, lack connection to their pre-cancer 
identity, and have a sense of disorientation (Bridges, 1991).  It is important to normalize 
survivors’ feelings of grief, sadness, and anger and caution them to assess quality of life 
improvements on a monthly basis, versus daily or weekly, in order to view changes more 
realistically (Rancour, 2008). 
 The second stage of Transitions Theory is the neutral zone (Bridges, 1991).  This 
stage is characterized by confusion and anxiety (Bridges, 1991).  During the diagnosis 
and treatment process, many women experience a heightened sense of anxiety and an 
urgency to act quickly and begin treatment.  As a result, little attention is paid to the 
meaning of the illness.  Breast cancer survivors enter the neutral zone when they begin to 
assess how the illness has changed their values, priorities, and identity (Rancour, 2008).  
At this point, survivors do not identify as cancer patients nor do they feel a sense of 
normalcy (Rancour, 2008).  This is an important period in the transitional process and 
38 
 
 
rushing through this stage, either independently or at the “encouragement” of others, can 
cause discomfort, anxiety, and panic (Bridges, 1991).  Finding a balance between solitary 
reflection (through silence, meditation, journaling) and rebuilding social connections can 
help survivors in this stage.  Further, survivors must be reassured that their new identity 
will emerge over time (Bridges, 1991), that is, that the experience is developmentally 
normal and will, with work, resolve in time. 
 The final stage of Transitions Theory is the new beginning (Bridges, 1991).  A 
survivor enters the new beginning when they have done the work necessary to transition 
through the first two stages and come to a resolution of how they will move forward 
(Rancour, 2008).  At this point, a new identity may emerge that includes a new life 
purpose or direction, changes in relationships, and development of new skills (Rancour, 
2008).   
 This theory is relevant to the current study because it promotes three primary 
skills: attending to feelings (allowing oneself to acknowledge feeling without judgment), 
befriending feelings (learning to tolerate and accept feelings), and surrendering to the 
suffering (fostering gentleness toward the self) (Rancour, 2008).  Each primary skill 
promoted through Transitions Theory relates to the individual constructs of the 
hypothesized path model that the impact of mindfulness on quality of life is mediated by 
self-kindness and alexithymia.  The first primary skill, attending to feelings, is a 
component of mindfulness, given that mindfulness involves a non-judgmental present 
orientation toward thoughts and feelings (Kabat-Zinn, 1990).  The second primary skill, 
befriending feelings, requires that one be able to identify, acknowledge, and describe 
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feelings.  People with alexithymia struggle to do this and, therefore, may find it more 
difficult to transition through difficult times.  The final primary skill, surrendering to the 
suffering, is essentially being kind toward one’s self.  This skill requires one to nurture 
self-kindness in times of difficulty.  According to Transitions Theory, these skills help 
people move through transitions into a place of acceptance and peace (Bridges, 1991).  
Mindfulness, self-kindness, and alexithymia may determine these skills levels and how 
the stages of transition are experienced.  Quality of life is a possible indicator for whether 
or not these stages of transition are being expressed fully and in a healthy manner. 
 It is important to recognize the element of time in transitioning from breast cancer 
patient to breast cancer survivor.  Transitions Theory clearly delineates three phases of 
transition that are time-oriented.  One must pass through the ending stage before arriving 
at the beginning stage.  Therefore, it is reasonable to suggest that the further out a breast 
cancer survivor is from active treatment, the more likely they are to have gone through 
the three stages of transition. 
Helping survivors to understand the stages of Transitions Theory and the skills 
associated with the theory may impact quality of life.  All three of the skills associated 
with Transitions Theory involve feelings.  Some breast cancer survivors struggle with 
identifying and describing feelings, however, or, in other words, have clinical or sub-
clinical alexithymia (Banner, 2009; Grassi, 2005; Manna et al., 2007). 
Alexithymia 
 Alexithymia involves restriction of emotions (Bagby, Parker, et al., 1994).  
Individuals with alexithymia have difficulty identifying, expressing, and distinguishing 
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between feelings or emotional arousal (Bagby, Parker, et al., 1994).  Alexithymia also is 
characterized by an external cognitive orientation (Bagby, Parker, et al., 1994).  While 
alexithymia prevalence rates for the general population are estimated to be between 5 and 
10% (Mattila et al., 2009), prevalence rates are higher in cancer survivors (26%) and, in 
particular, breast cancer survivors (36%) (Grassi, 2005; Manna et al., 2007).  
Alexithymia has been associated with increased severity of fatigue and depression 
(Bodini et al., 2008), anxiety (Banner, 2009), chronic pain (Lumley, 1997), and lower 
levels of social support, increased stress, and decreased well-being (Posse, Hallstrom, & 
Backenroth-Ohsako, 2002).  All of these associations have the potential to affect quality 
of life in breast cancer survivors. 
Alexithymia as Important to Quality of Life 
 Alexithymia has been found to be associated with lower levels of health-related 
quality of life in the general population (Mattila et al., 2009), though researchers have not 
investigated the relationship between alexithymia and quality of life specifically in a 
sample of breast cancer survivors.  It seems, clear, however, that fear of disease 
recurrence and fear of the future are elements of quality of life for breast cancer 
survivors.  What the survivor does with this fear (for example, experience and express the 
fear versus deny and suppress the fear) may play a role in quality of life.  In fact, fear of 
the future (e.g., disease recurrence, dying, lack of control) is one of the most stressful 
issues for breast cancer survivors (Lebel et al., 2009).  One implication of this finding is 
that helping breast cancer survivors learn to cope with their emotional distress may 
decrease the level of fear they experience.  In order to do this it is important to assess 
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breast cancer survivors for alexithymia to better understand their capacity to understand, 
experience, and express their emotional experience. 
 Social support, another important aspect of quality of life for breast cancer 
survivors (Brady et al., 1997) has been found to be lower in individuals with alexithymia 
(Posse et al., 2002).  One explanation for this involves attachment anxiety, which is that 
the same mechanisms that lead a person to repress emotions also lead them to isolate 
socially.  Mallinckrodt and Wei (2005) used a bootstrapping model to determine that 
those with low levels of emotional expression, as measured by an alexithymia scale, 
found it more difficult to form adult attachments and, therefore, to garner social support.  
While inhibited emotional expression has been linked to diminished social support, it also 
has been linked to lower physical well-being in cancer survivors (Porcelli et al., 2007).  
According to Pennebaker (1997), emotional restriction drains the body of vital energy 
needed for optimal well-being and taxes the immune system, vascular system, and 
nervous system.  As a result, this can prevent the body from healing and revitalizing 
necessary systems in the face of a disease threat (Pennebaker, 1997).  
Alexithymia and Breast Cancer 
 Though the traumatic nature of a breast cancer diagnosis may be considered a 
possible explanation for the high prevalence of alexithymia in breast cancer survivors, 
alexithymia has been found to be a relatively stable trait in this population (Luminet, 
Rokbani, Ogez, & Jadoulle, 2007).  It is unclear how this might impact the transition 
from breast cancer patient to survivor.  It is known that transitioning to survivorship can 
be a difficult and uncertain time and emotional expression and social support can lessen 
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the severity of this (Morgan, 2009).  Further, it is known that alexithymia is related to 
depression, fatigue, increased perceived pain, and lower emotional well-being (Banner, 
2009; Bodini et al., 2008; Lumley, 1997; Posse et al., 2002).  What is unknown, however, 
is how alexithymia impacts quality of life for breast cancer survivors during the initial 
transition period.   
Mindfulness 
 Mindfulness is a non-judgmental awareness of the present moment that includes a 
present orientation to thoughts, feelings, and senses (Kabat-Zinn, 1990).  Mindfulness 
can be defined as nonreactivity to inner experiences (noticing senses and thoughts 
without reacting to them), observing (an awareness of the present moment), acting with 
awareness (paying attention to the present moment), describing (describing feelings and 
thoughts), and nonjudging of experience (noticing the present moment without labeling it 
good or bad) (Baer et al., 2006).  Mindfulness also has been defined as a way of being in 
life, rather than a technique for stress reduction (Smith, Richardson, Hoffman, Pilkington, 
2004).  Buddha taught that “mindfulness is all helpful” (p. 37).  With mindfulness, one is 
able to direct attention to the inner workings of the mind and body.  The seventh principle 
of Buddhist psychology is that mindful attention can be liberating and bring perspective, 
balance, and freedom to individuals (Kornfield, 2009).  For over a thousand years, 
Buddhist monks have practiced the art of mindfulness in order to achieve wisdom and 
“inner illumination” (Kornfield, 2009).  Increasingly, though, it seems clear that 
mindfulness can be taught.  Jon Kabat-Zinn developed one of the most popular training 
programs, an 8-week Mindfulness Based Stress Reduction (MBSR) program, which 
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involves yoga and meditation, including daily practice of 45 minute long meditation tapes 
(Kabat-Zinn, 1990).  The core practice of MBSR is mindful breathing (focusing on the 
breath by observing the rise and fall of each breathe) but a strong commitment to practice 
and an open attitude also are essential components of learning to be mindful (Kabat-Zinn, 
1990).  This is because mindfulness requires active participation in paying attention to the 
present moment.  One cannot passively be mindful or have mindfulness done to them.  
Rather, mindfulness is a state of being that comes from within and requires focus and 
attention (Kabat-Zinn, 1990).    
Mindfulness as Important to Quality of Life 
 The benefits of practicing mindfulness include improvements in symptoms of 
stress, mood disturbance, and health-related challenges In a meta-analysis of 20 studies 
on mindfulness training among samples with various cancer diagnoses, chronic pain, 
fibromyalgia, coronary heart disease, depression, anxiety, and eating disorders, a 
significant effect of medium size was found for the impact of mindfulness on mental 
health (d = 0.54, 95% CI 0.39-0.68, p < .001) and physical health (d = 0.53, 95% CI 0.23-
0.81, p = .0004) (Grossman, Niemann, Schmidt, & Walach, 2004).  The results of this 
meta-analysis suggest that MBSR training is a useful intervention for a range of chronic 
problems.  This seems particularly true as the studies included in the Grossman et al. 
(2004) meta-analysis included various dependent measures, including psychological 
dimensions of quality of life, depression, anxiety, coping styles, sensory pain, and 
physical well-being.   
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 MBSR has been found to improve overall quality of life and areas related to 
quality of life such as emotional well-being (Brotto & Heiman, 2007; Foley, Huxter, 
Baillie, & Price, 2010; Kuyken et al., 2008; Roemer, Orsillo, Salters-Pedneault, 2008).  
In a recent study, Foley et al. (2010) investigated the impact of Mindfulness-Based 
Cognitive Therapy (MBCT) on quality of life and emotional well-being among 115 
cancer patients.  MBCT is similar to MBSR but also includes an emphasis on mindful 
awareness of cognitive ruminations.  Foley et al. assigned participants to either a 
treatment group or a wait-list control group.  Breast cancer patients comprised 47.3% of 
the sample, women comprised 77% of the sample, and the mean age of participants was 
55.18.  The treatment group received an 8-week mindfulness training program that 
included 2 hour weekly sessions, daily home practice of up to one hour, and 40 minute 
tape recordings of standard meditations (body scan, walking meditation, and general 
mindfulness meditation).  Each treatment group included 8 to 12 participants.  The wait-
list group served as the control group and received the mindfulness training upon 
completion of the study.  Outcome measures included depression as measured by the 
Hamilton Rating Scale for Depression (Williams, 1988), anxiety as measured by the 
Hamilton Anxiety Rating Scale (Shear et al., 2001), distress as measured by the 
Depression, Anxiety, Stress Scale (Lovibond & Lovibond, 1995), quality of life as 
measured by The Functional Assessment of Cancer Therapy-General (Cella et al., 1993), 
and mindfulness as measured by the Frieburg Mindfulness Inventory (Walach, Buchheld, 
Buttenmuller, Kleinknecht, & Schmidt, 2006).  Data were collected pre and post 
intervention and the treatment group received a 12-week follow-up assessment post-
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intervention.  Initial pre-intervention results indicated that both groups fell within the 
moderately depressed range, mildly anxious range, and had below average ratings for 
quality of life.  Further, the two groups did not differ significantly at baseline.  Post-
intervention results revealed that the treatment group had significantly greater 
improvement for depression (F(1, 166) = 18.78, p < .001), anxiety (F(1, 115) = 10.25, p 
= .002) and mindfulness (F(1, 115) = 18.51, p < .001).  Change in quality of life was not 
significant at the established alpha level of .01 (F(1, 12) = 6.70, p = .011) but the 
difference would have been significant had a more liberal alpha level, such as .05, been 
used.  These results provide support for the use of mindfulness interventions to improve 
overall quality of life and emotional well-being.   
Similarly, Kuyken et al. (2008) found mindfulness to have a positive impact on 
recurrent depression for women In this study, the researchers assigned 123 women (the 
sample was not breast cancer survivors) between the ages of 21 and 72 to either an 
intervention group or a standard treatment group for depression relapse prevention.  The 
intervention group involved an 8-week mindfulness training program with an additional 
focus of helping women taper from their antidepressant medications; the standard care 
(control group) included continuation of antidepressant medication.  Women completed 
assessments at 3-month intervals for 15 months.  Outcome measures were collected for 
quality of life, depressive symptoms, and possible relapse.  Results indicated that over a 
15-month period, 47% of the intervention group experienced a relapse of depression 
compared to 60% of the standard care group.  Though there was a trend toward higher 
quality of life for the intervention group, results were non-significant.  These findings 
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suggest that mindfulness may assist women as they transition from a difficult time 
(depression) and off of psychotropic medications.  This has possible implications for 
breast cancer survivors who are transitioning off of medications for anxiety or 
depression. 
Mindfulness has been found to improve additional areas of quality of life as well.  
Recently, researchers investigated the relationship between mindfulness and sexual body 
image (Fink, Foran, Sweeney, & O’Hea, 2009).  Although the study did not target cancer 
survivors, it is a relevant study nonetheless because many breast cancer survivors have 
identified body image and sexuality as primary concerns (Schover et al., 1995).  In this 
study, 79 female undergraduate students were asked to complete the Five Factor 
Mindfulness Questionnaire (FFMQ; Baer et al., 2006) and the Sexual Attractiveness 
subscale of the Body Esteem Scale (BES; Franzoi & Shields, 1984).  Based on a multiple 
regression analysis, the total score for the FFMQ was significantly predictive of scores 
for the Sexual Attractiveness subscale of the BES.  Further, two subscales of the FFMQ, 
the Observing subscale and the Describing subscale, were found to be uniquely predictive 
of the Sexual Attractiveness subscale.  This means the ability to pay attention to internal 
experience (Observing) and label these experiences with words (Describing) was 
predictive of higher self-perception of sexual attractiveness.  Results of this study have 
limited generalizability, however, as it included a small sample of undergraduate students 
only.  It is unknown the extent to which these findings would generalize to cancer 
survivors. 
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Mindfulness and Breast Cancer 
 Researchers have begun to investigate mindfulness in women with breast cancer.  
Witek-Janusek et al. (2008) evaluated the effect of mindfulness on immune function, 
quality of life, and coping in women with breast cancer.  Seventy-five women between 
the ages of 35 to 75 who were post-surgery participated in this study.  Women who 
underwent chemotherapy were excluded from the study.  Forty-four women were 
assigned to an eight week MBSR treatment group and 31 were assigned to a control 
group.  Immune markers, quality of life, coping, and cortisol (a stress hormone) were 
measured at four points throughout the study: pre-MBSR, four weeks after the start of the 
MBSR group, upon completion of the MBSR group, and one month after the MBSR.  
Quality of life was measured by the Quality of Life Index (Ferrans, 1990), coping was 
measured by the Jalowiec Coping Scale (Jalowiec, Murphy, & Powers, 1984), 
mindfulness was measured by the Mindfulness Attention Awareness Scale (Carlson & 
Brown, 2005), immune markers and cortisol were measured by a series of blood samples 
including peripheral blood mononuclear cells, natural killer cell activity, and cytokines.  
Immunological assessments revealed that women in the MBSR group experienced a 
decrease in IL-4 and IL-6 (a positive indication of immunity enhancement) and re-
established a healthy level of natural killer cells and cytokines.  Further, the MBSR group 
experienced a decrease in the stress hormone cortisol.  The control group, on the other 
hand, did not show evidence of immunity enhancement.  Women in the MBSR group 
also reported significant improvement in their overall quality of life when compared to 
the control group.  It is noteworthy that the greatest improvement in quality of life 
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occurred in the psychological-spiritual and family domains.  In terms of coping, the 
MBSR group demonstrated higher levels of being optimistic (positive thinking) and 
supportant coping (use of personal, professional, and spiritual resources) compared to the 
control group. 
 In a similar study, Carlson et al. (2004) investigated the impact of a MBSR 
program on breast and prostate cancer outpatients.  Patients were eligible to participate in 
the study if they were over the age of 18, had early stage breast or prostate cancer, were a 
minimum of three months post-surgery, and were not receiving adjuvant therapies at the 
time of the study.  Forty-three patients participated in the study including 34 women with 
breast cancer and 9 men with prostate cancer.  In a pre-post intervention design, the 
patients completed an eight week MBSR group.  Blood and saliva samples were collected 
to measure cortisol and hormone levels.  Participants also completed a health behavior 
form (recorded sleep, alcohol consumption, caffeine, smoking), weekly meditation form, 
quality of life assessment (European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire; Aaronson et al., 1993), and measures of mood (Profile of 
Mood States, McNair, Lorr, & Droppelman, 1971) and stress (Symptoms of Stress 
Inventory, Leckie and Thompson, 1979).  Only the global scores of the psychological 
tests were reported.  In the sample, pre-post quality of life scores significantly increased 
(t = -2.23, p < 0.05).There were no changes, however, in mood scores based on the 
Profile of Moods States.  Post-intervention stress scores were significantly lower (t = 
3.23, p < 0.01) indicating reduced stress levels.  Though there were no significant 
changes in cortisol, it was reported that those with lower levels of afternoon cortisol 
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reported higher levels of quality of life.  In a one year follow-up (Carlson, Speca, Faris, & 
Patel, 2007), results were similar and positive gains appeared to be maintained.  One 
positive outcome was noted at follow-up that was not detected in the original study as 
cortisol levels were decreased significantly at follow-up, indicating a reduction in stress. 
 Finally, in a study on mindfulness and women with breast cancer (Tacon, Caldera, 
& Ronaghan, 2004), 27 women with breast cancer between the ages of 30 and 75 were 
recruited to participate in an eight week MBSR program that met weekly for 1.5 hours.  
At the time of the study, only 3 women were currently undergoing radiation and 
chemotherapy.  The remaining women were taking oral medication.  A pre-post design 
was implemented to assess for anxiety as measured by the State-Trait Anxiety Inventory 
(Spielberger, 1983), stress as measured by a single 10-point scale question, mental 
adjustment to cancer as measured by the Mental Adjustment to Cancer (Watson et al., 
1988), and health locus of control as measured by the Multidimensional Health Locus of 
Control Scale (Wallston, Wallston, & DeVellis, 1978).  Results indicated a significant 
reduction in stress (t(26) = 7.54, p < .001) and anxiety (t(26) = 4.95, p < .001) following 
the MBSR program.  Further, there was a significant reduction in two types of responses 
to cancer: helplessness-hopelessness (t(26) = 2.66, p < .01) and anxious preoccupation 
(t(26) = 2.54, p < .01).  Scores on the health locus of control reflected an increase in 
internal locus of control. 
 Much is known, then, about the importance of mindfulness to psychological and 
physical well-being.  Though it seems clear that mindfulness positively impacts quality of 
life in breast cancer patients, limited empirical data is available on the impact of 
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mindfulness on breast cancer survivors who have completed surgery and all adjuvant 
treatments.  Further, less is known about the mediating factors of mindfulness on quality 
of life in breast cancer survivors. 
Self-Kindness 
 Self-kindness is defined as extending kindness, understanding, and acceptance 
toward oneself (Neff, 2003).  Self-kindness involves letting go of harsh judgments and 
self-criticisms in favor of loving and gentle acceptance (Neff, 2003).  The origins of the 
construct self-kindness lay in Buddhist psychology (Kornfield, 2009), strengths-based 
counseling (Fong, 1990), and Neff’s (2003) work on self-compassion.   
One of the primary principles of Buddhist psychology is to acknowledge and see 
the inner nobility and beauty in all people (Kornfield, 2009).  This includes having 
openness to one’s own goodness, referred to as one’s Buddha nature (Kornfield, 2009).  
Far too often, however, people cling to fears and darker elements of oneself (e.g., feelings 
of inadequacy, approval seeking) rather than embracing one’s strengths and virtues.  
Robert Johnson (1991) wrote that “it is more disrupting to find that you have a profound 
nobility of character than to find out you are a bum” (p. 8).  Loving-kindness meditation 
is a way to cultivate self-kindness.  The Pali (Buddha’s language) word for loving 
kindness, metta, means universal, all-embracing love (Germer, 2009).  In the fifth century 
CE, a Buddhist monk Buddhaghosa detailed instructions for metta meditation.  An 
example of one of Buddhaghosa’s metta meditations is to repeat the phrases “May I be 
happy and free from suffering” and “May I keep myself free from enmity, affliction, and 
anxiety and live happily” (Germer, 2009, p. 137). 
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Self-kindness also is grounded in counseling’s strength-based, developmental, 
wellness orientation (Fong, 1990; Myers, 1992; Witmer & Sweeney, 1992).  Based on 
this orientation, positive emotions, traits, and resources are identified and expanded upon.  
This orientation contrasts the medical, illness-oriented model, which is problem-focused 
and highlights what is wrong with human nature (Myers, 1992).  Though it is useful to be 
able to fully understand people’s problems in order to help them, a risk exists of solely 
focusing on fears, depression, anxiety, and anger while leaving resilient and affirming 
qualities in the shadow.  A developmental, wellness orientation suggests that problems 
are a part of life and should be viewed as opportunities for personal growth and renewal 
(Myers, 1992).  Furthermore, healthy development and wellness is strived for by means 
of utilizing the positive forces that presently exist within an individual.  It is accepted 
within counseling that positive thoughts and emotions must be nurtured and fostered for 
optimal living.  Self-kindness is an example of a positive construct that, if nurtured, has 
the potential to improve quality of life. 
Little research has been conducted on self-kindness and, to date, no studies on 
self-kindness among breast cancer survivors have been published.  Kristen Neff is 
leading the way in research on the similar construct of self-compassion (Neff, 2003).  
Based on Neff’s work, self-kindness is a distinct subscale of the construct of self-
compassion.  Neff (2009) described self-kindness as being warm toward oneself in the 
light of suffering, failure, and pain.  Further, it involves accepting reality with sympathy 
and kindness toward oneself.  In a study aimed at investigating the construct validity of 
the Self-Compassion Scale (Neff, 2003), two groups were compared to each other.  One 
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group included practicing Buddhists and the other group included undergraduate 
university students.  Because self-compassion and the components of self-compassion, 
including self-kindness, are rooted in Buddhist psychology, Neff chose to sample from 
Buddhists under the assumption that they would have been exposed to teachings of being 
kind and compassionate to oneself.  The research groups were comprised of 43 Buddhist 
participants and 232 undergraduate student participants.  The group with Buddhist 
participants included 16 men and 27 women.  The mean age was 47 years old and the 
standard deviation was 9.71.  The majority of the sample was White (91%).  Participants 
reported practicing Buddhist meditation between 1 and 40 years.  All participants in both 
groups were asked to complete the Self-Compassion Scale and a self-esteem scale.  
Results revealed a significant between groups difference for the self-kindness subscale 
(F(1, 27) = 32.00, p < .001).  The mean self-kindness score for the group with Buddhist 
participants was 3.77 with a standard deviation of 0.79.  The mean self-kindness score for 
the group with undergraduate students was 2.99 with a standard deviation of 0.78.  What 
is not clear, however, is whether the difference between groups is a function of Buddhist 
practice or a function of age.  In either case, there is evidence for the discriminant validity 
of the Self-Compassion Scale, but more research is needed around these constructs.  
Theoretical and limited empirical evidence suggests self-kindness may be a positive 
construct that can be taught over time (Neff, 2003, 2009; Neff, Rude, & Kirkpatrick, 
2007). 
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Self-kindness as Important to Quality of Life 
 Researchers have yet to investigate the direct impact of self-kindness on quality of 
life.  Similar to the current study, however, Kraus and Sears (2009) hypothesized that 
self-kindness may be a mediator for mindfulness, which in turn can impact quality of life.  
They further suggested that though mindfulness often is used to create awareness and 
observation, it also may serve (through a pathway of self-kindness) to promote increased 
tolerance to distressing emotions by cultivating positive qualities such as friendliness, 
joy, and acceptance (Kraus & Sears, 2009).  Kraus and Sears (2009) developed the Self-
Other Four Immeasurables (SOFI) scale to assess both the positive and negative aspects 
of the mindfulness experience.  Buddhist teachings on the Four Immeasurables, loving-
kindness (metta), compassion (karuna), joy (mudita), and equanimity (upekkha), and their 
opposites (hatred, cruelty, anger, and jealousy) were used to develop the scale.  One 
hundred and twenty-four undergraduate students and 12 experienced meditators 
participated in the scale development study.  Loving-kindness, compassion, and joy were 
measured, in addition to social desirability, mindfulness, positive and negative affect, and 
self-compassion.  High internal consistency was found for each subscale: Positive Self (α 
= 0.86), Negative Self (α = 0.85), Positive Other (α = 0.80), Negative Other (α = 0.82).  
However, internal consistency for the overall measure was not as strong (α = 0.60).  
Based on factor analyses, the Four Immeasurables did not converge as expected.  Instead, 
the scales loaded based on positive qualities versus negative qualities and self versus 
other ratings.  The SOFI demonstrated strong discriminant, concurrent, and construct 
validity.  This suggests that the SOFI may be used to assess for positive qualities 
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associated with mindfulness, thus providing a clinical and research tool for assessing 
positive constructs such as self-kindness.   
It seems apparent that developing positive qualities, such as self-kindness, can 
serve to build personal resources.  Fredrickson, Cohn, Coffey, Pek, and Finkel (2008) 
investigated the impact of a 6-week intervention of loving-kindness instruction on 
enhancing positive emotions and building personal resources (e.g., the ability to give and 
receive emotional support and the ability to fight off a common cold).  In this study, 139 
Compuware Corporation employees participated in a 6-week course on loving-kindness 
meditation.  Sixty-seven participants were randomly assigned to the loving-kindness 
group and 72 participants were assigned to the waitlist control group.  Over half of the 
participants were female (65.5%) and Caucasian (72.6%).  The mean age was 41 years.  
The training included six weekly one-hour sessions of instruction and practice of 
meditation directing love and kindness to themselves and others.  In a pre-post design, the 
personal resources measured included mindfulness, agency thinking (belief that one is 
able to meet goals) and pathway thinking (belief that multiple ways exist to achieve 
goals), tendency to enjoy pleasant experiences, optimism, ego-resilience, psychological 
well-being, social support, positive relations to others, illness symptoms, sleep duration, 
satisfaction with life, and depression.  The hypothesized path model suggested that 
loving-kindness meditation would increase positive emotions, which would increase 
personal resources, thereby increasing overall life satisfaction.  Results indicated that this 
path was significant for nine resources tested: mindfulness, pathway thinking, tendency 
to enjoy pleasant experiences, environmental mastery, self-acceptance, purpose in life, 
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social support, positive relations with others, and illness symptoms.  In other words, 
loving-kindness training significantly increased positive emotions over time, which 
increased select resources, which, in turn, was associated with significant increases in life 
satisfaction. 
Self-kindness and Breast Cancer 
To date, researchers have not studied the impact of self-kindness on breast cancer 
survivors.  Based on the aforementioned theories, however, it is viable that self-kindness 
has the potential to elicit positive emotions in breast cancer survivors.  Also, it seems 
plausible that these positive emotions could have an impact on emotional and physical 
quality of life.  Self-kindness can be viewed as important to breast cancer survivors based 
on Buddhist psychology.  Buddhist psychology asserts that the human body is highly 
valued and deemed a priority for self-care (Kornfield, 2009).  Regardless of one’s age or 
life circumstance (e.g., surviving breast cancer), it is important to be kind and nurturing 
to one’s body.  Kornfield wrote that:  
 
when physical illness arises, it often diminishes our sense of dignity.  With this 
can also come shame and self-hatred.  We can take the illness personally, as if it is 
our fault.  But sickness and health are part of every human life.  When our hearts 
open with understanding we will treat this body and mind with kindness no matter 
what the circumstances. (p. 117) 
 
 
 This kindness has the potential to help create an environment for healing and life 
enhancement over time.  Considering the challenges breast cancer survivors encounter as 
they recover from the physical and emotional sequelae of the diagnosis, treatment, and 
transition to survivorship, self-kindness could have a significant impact on their lives.  
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Germer (2009) wrote that self-kindness is only the beginning of life enhancement.  
Ultimately, caring and being gentle with oneself leads to deeper more intimate caring of 
others and, in the Dali Lama’s teachings, self-kindness precedes the expression of love 
and caring to others (Germer, 2009).   
Summary 
 In this chapter, a review of the literature related to the experience of breast cancer 
and survivorship has been provided.  Specifically, research pertaining to quality of life, 
alexithymia, mindfulness, and self-kindness was presented.  Additionally, theory on 
transition was related to the experience of breast cancer survivorship.  In summary, the 
following highlights were made: (a) treatment for breast cancer results in physical and 
emotional burdens that impact survivorship for women, (b) alexithymia is prevalent in 
breast cancer survivors and may exacerbate the negative emotional and physical 
outcomes of the disease, (c) mindfulness may support women as they transition into 
survivorship and positively impact quality of life, and (d) self-kindness may induce 
positive emotions and enhance personal resources that have the potential to impact 
quality of life.  The proposed study seeks to fill the gaps by focusing on breast cancer 
survivors.  More specifically, alexithymia and self-kindness will be explored as possible 
mediators of the relationship between mindfulness and quality of life in breast cancer 
survivors. 
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CHAPTER III 
 
METHODOLOGY 
 
 
In Chapters I and II, a study on mindfulness, self-kindness, alexithymia, and 
quality of life was introduced, a rationale was established, and a review of the relevant 
literature was provided.  The review of the literature in Chapter II supported the need for 
further study of mindfulness, self-kindness, alexithymia, and quality of life, and offered 
the possibility that self-kindess and alexithymia may serve to mediate the relationship 
between mindfulness and quality of life.  The current chapter includes a description of the 
methodology for the current pilot study including hypotheses, participants, 
instrumentation, data analysis, and procedures. 
Research Questions and Hypotheses  
Research Question 1: What is the effect of time since completion of treatment (in 
months) on mindfulness, alexithymia, self-kindness, and quality of life for female 
survivors of breast cancer (Stages 0-III) and the relationship among mindfulness, 
alexithymia, self-kindness, and quality of life for female survivors of breast cancer 
(Stages 0-III)? 
Hypothesis 1a: Time since completion of treatment will have an effect on quality 
of life such that those further out from completion of treatment will report higher 
quality of life. 
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Hypothesis 1b: Mindfulness will be significantly positively correlated with self-
kindness and quality of life. 
 Hypothesis 1c: Alexithymia will be significantly negatively correlated with 
mindfulness, self-kindness, and quality of life.   
Research Question 2: What are the effects of cancer stage (0-III) on mean scores of 
mindfulness, alexithymia, self-kindness, and quality of life among female survivors of 
breast cancer?  
Hypothesis 2: Cancer stage will have main effects on all study variables, such that 
persons with higher stages of cancer will report lower levels of mindfulness, self-
kindness, and quality of life, and higher levels of alexithymia.  
Research Question 3: What are the effects of surgery (i.e., none, lumpectomy, or 
mastectomy) and adjuvant therapy (i.e., none, hormone therapy, chemotherapy, or 
radiation) on mean scores of mindfulness, alexithymia, self-kindness, and quality of life 
among female survivors of breast cancer?  
Hypothesis 3a: Type of surgery will have a main effect on all study variables, 
such that persons who experience more invasive surgery will report lower levels 
of mindfulness, self-kindness, and quality of life, and a higher level of 
alexithymia. 
Hypothesis 3b: Chemotherapy will have an effect on mean scores of mindfulness, 
self-kindness, alexithymia, and quality of life, such that persons who receive 
chemotherapy will report lower levels of mindfulness, self-kindness, and quality 
of life, and higher levels of alexithymia. 
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Research Question 4: What are the relationships among mindfulness, alexithymia, self-
kindness, and quality of life within a path model that specifies a relationship between 
mindfulness and quality of life mediated by alexithymia and self-kindness? 
Hypothesis 4: The hypothesized path model specifying a relationship between 
mindfulness and quality of life mediated by alexithymia and self-kindness will 
account for a statistically significant amount of the variance in quality of life.   
Participants 
The population for this study is female survivors of Stages 0 to III breast cancer 
who have completed surgery and adjuvant therapy within the past two years.  Participants 
were recruited from three primary sources.  First, women were recruited from Cancer 
Services, a non-profit agency in the Southeast that provides cancer services and resources 
to women with cancer.  A recruitment mailing was distributed to approximately 1,200 
clients from Cancer Services’ database of current clients and alumni that included an 
advertisement for the study.  Second, Cancer Services’ clients also were recruited at a 
regional breast cancer conference hosted by Cancer Services.  Finally, participants were 
recruited from a cancer survivor wellness group that was comprised of recent cancer 
survivors.  All group members received medical treatment from a regional cancer center 
in the Southeast.  Group participants received recruitment emails advertising the study.   
Using G*Power 3, an a priori power analysis (Faul, Erdfelder, Lang, & Buchner, 
2007), a suggested sample size of 120 is needed for a minimum power of .80 and a 
moderate effect size of .25.  This sample size was determined based on the required 
analysis for research question three, which required the largest sample size.   
60 
 
 
Procedures 
Instrumentation 
Participants will complete one web-based series of instruments that includes a 
demographic questionnaire, the Functional Assessment of Cancer Therapy-Breast (Brady 
et al., 1997), the Twenty-item Toronto Alexithymia Scale (Bagby, Parker, et al., 1994; 
Bagby, Taylor, & Parker, 1994) the Five Factor Mindfulness Questionnaire (Baer et al., 
2006), and the Self-Compassion Scale (Neff, 2003).  The demographic questionnaire will 
always be first in the instrument packet, but the remaining order of the instruments will 
be randomized to prevent the potential for ordering effects, particularly given that fatigue 
could be an issue for some participants.  The psychometric properties of the four 
instruments are discussed below.  Additionally, permissions from the authors to use all 
four instruments are included in Appendix B. 
Functional Assessment of Cancer Therapy-Breast.  Quality of life will be 
measured using the Functional Assessment of Cancer Therapy-Breast (FACT-B; Brady et 
al., 1997).  The FACT-B is a 44-item self-report instrument with a 5-point Likert-type 
scale ranging from 0 (not at all) to 4 (very much).  The FACT-B has six subscales that 
include physical well-being (e.g., “I have a lack of energy”), social/family well-being 
(e.g., “I get emotional support from my family”), relationship with doctor (e.g., “My 
doctor is available to answer my questions”), emotional well-being (e.g., “I feel sad”), 
functional well-being (e.g., “I am able to work”), and additional concerns as they relate 
to breast cancer (e.g., “I feel sexually unattractive”).  The FACT-B was normed on two 
samples of women with breast cancer.  Internal consistency for the six subscales ranged 
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from 0.63 to 0.86 and the alpha coefficient for the overall score for quality of life was 
0.90.  Acceptable support was provided for one week test-retest reliability (.88 for breast 
cancer scale and .85 for total score).  Construct validity was evidenced through strong, 
positive correlations with another quality of life measure (r = .86, p < .001) and expected 
negative correlations for a mood assessment (r = -.70, p < .001; r = -.66, p < .001) (Brady 
et al., 1997).  For the purpose of this study, the unit of analysis will be the global quality 
of life score.   
 Toronto Alexithymia Scale-20.  The 20-item Toronto Alexithymia Scale (TAS-
20; Bagby, Parker, et al., 1994; Bagby, Taylor, et al., 1994) will be used to measure 
alexithymia.  The TAS-20 is a 20-item instrument with three scales related to 
alexithymia: (a) difficulty identifying feelings (e.g., “I am often confused about what 
emotion I am feeling,” (b) difficulty describing feelings (e.g., “It is difficult for me to 
find the right words for my feelings”), and (c) externally oriented thinking (e.g., “I prefer 
to analyze problems rather than just describe them”).  For the current study, the global 
scale measure of alexithymia will serve as the unit of analysis.  All items are measured on 
a 5-point Likert-type scale ranging from 1 (not at all like me) to 5 (completely like me).  
Total scores can range from 20 to 100.  Higher scores are equated with higher levels of 
alexithymia (i.e., difficulty expressing emotions).  The TAS-20 was normed on samples 
of male and female university undergraduate students (mean age was 21.1) and male and 
female psychiatric out-patients (mean age was 36.62) (Bagby, Parker, et al., 1994; Bagby, 
Taylor, et al., 1994).  Bagby, Parker, et al. (1994) reported a Cronbach’s alpha of 0.81 for 
the total score, indicated acceptable internal consistency.  Weaker alphas of 0.78 
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(subscale 1), 0.75 (subscale 2), and 0.66 (subscale 3) for the three subscales further 
support use of the global scale.  Bagby, Parker, et al. (1994) also reported acceptable 
three week test-retest reliability (0.77, p < 0.01).  Validity was obtained by administering 
the TAS-20 and four additional assessments of psychological mindedness, need for 
cognition, psychosomatics, and a personality inventory to undergraduate students and 
clients from a metropolitan outpatient clinic (Bagby, Taylor, et al., 1994).  The TAS-20 
had a strong, negative correlation with psychological mindedness, need for cognition, 
positive emotions, and assertiveness.  The TAS-20 also had strong, positive correlations 
with depression, anxiety, and self-consciousness (Bagby, Taylor, et al., 1994).   
 Five Facet Mindfulness Questionnaire.  The Five Facet Mindfulness 
Questionnaire (FFMQ; Baer et al., 2006) will be used to measure mindfulness.  The 
FFMQ is a 39-item self-report instrument that measures five facets of mindfulness: (a) 
observing, (b) describing, (c) acting with awareness, (d) nonjudging, and (e) nonreacting.  
Observing is defined as the level at which one notices internal and external sensations 
and stimuli (e.g., “When I take a shower or a bath I stay alert to the sensations of water 
on my body”).  Describing is defined as the level at which one is able to describe their 
observations (e.g., “I am good at finding the words to describe my feelings”).  Acting 
with awareness is defined as the level at which one is in the present moment and paying 
attention to one’s activity and experiences (e.g., “I find it difficult to stay focused on 
what’s happening in the present”).  Nonjudging is defined as the level at which one 
avoids evaluating one’s experiences and observations (e.g., “I criticize myself for having 
irrational or inappropriate emotions”).  Nonreacting is defined as the level at which one is 
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able to notice internal and external observations without reacting to them (e.g., “I 
perceive my feelings and emotions without having to react to them”).  The FFMQ is 
measured using a 5-point Likert-type scale ranging from 1 (never or very rarely true) to 5 
(very often or always true).  The FFMQ provides a global score for mindfulness and 
individual subscale scores.  For the purposes of this study, the unit of analysis will be the 
global measure of mindfulness.   
A sample of male and female undergraduate students was used to norm the FFMQ 
(Baer et al., 2006).  The instrument was found to measure distinct aspects of mindfulness.  
An exploratory factor analysis indicated that the five-factor model accounted for 33% of 
the variance and was a good fit.  Confirmatory factory analysis further concluded that the 
model was a good fit.  The FFMQ has been reported to have strong internal consistency 
with Cronbach’s alpha of .75 for nonreactivity, .83 for observing, .87 for acting with 
awareness, .91 for describing, .87 for nonjudging, and .96 for the full scale score (Baer et 
al., 2006). 
Self-Compassion Scale.  The Self-Compassion Scale (SCS; Neff, 2003) will be 
used to measure self-kindness.  The SCS is a 26-item instrument with six subscales: self-
kindness (e.g., “When I’m going through a very hard time, I give myself the caring and 
tenderness I need”) versus self-judgment (“When I see aspects of myself that I don’t like, 
I get down on myself”), common humanity (“When I feel inadequate in some way, I try to 
remind myself that feelings of inadequacy are shared by most people”) versus isolation 
(“When I fail at something that’s important to me I tend to feel alone in my failure”), and 
mindfulness (“When something upsets me I try to keep my emotions in balance”) versus 
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over-identification (“When I fail at something important to me I become consumed by 
feelings of inadequacy”).  The SCS was normed on samples of male and female 
undergraduate students and male and female practicing Buddhists.  Acceptable internal 
consistency has been reported for all subscales, with the self-kindness subscale having a 
reported alpha of .77 (Neff, 2003).  Construct validity was obtained through significant 
correlations with self-criticism (r = -.65, p < .01), social connectedness (r = .41, p < .01), 
depression (r = -.51, p < .01), and anxiety (r = -.65, p < .01) scales (Neff, 2003).  The 
SCS demonstrated acceptable three week test-retest reliability for the self-kindness 
subscale (.88).  For the purpose of this study, the unit of analysis will be the self-kindness 
subscale score. 
Demographic questionnaire.  A demographic questionnaire was created by the 
researcher to collect relevant information including: age, stage of breast cancer, date of 
last adjuvant treatment, type of adjuvant treatment received, date of last surgical 
treatment, and type of surgical treatment received.  A copy of the demographic 
questionnaire is included in Appendix B. 
Data Analysis 
Descriptive statistics will be used to describe the characteristics of the sample 
based on the data from the demographic questionnaire.  Alpha coefficients will be 
calculated to determine the reliability of each of the measures for this sample, and 
analyses will be conducted to test each of the research hypotheses. 
To test hypothesis 1a (Time since completion of treatment will have an effect on 
quality of life such that those further out from completion of treatment will report higher 
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quality of life), an ANOVA will be used to examine the effect of time on quality of life.  
To test Hypothesis 1b (Mindfulness will be significantly positively related with self-
kindness and quality of life) and Hypothesis 1c (alexithymia will be significantly 
negatively correlated with mindfulness, self-kindness, and quality of life), a Pearson-
Product Moment Correlation will be used to examine the relationships among 
mindfulness, alexithymia, self-kindness, and quality of life.  To test Hypothesis 2 (Cancer 
stage will have main effects on all study variables, such that persons with higher stages of 
cancer will report lower levels of mindfulness, self-kindness and quality of life, and 
higher levels of alexithymia), an analysis of variance (ANOVA) will be used to assess for 
main effects of cancer stage.  To test Hypothesis 3a (Type of surgery will have a main 
effect on all study variables, such that persons who experience more invasive surgery will 
report lower levels of mindfulness, self-kindness, and quality of life, and a higher level of 
alexithymia.) and Hypothesis 3b (Chemotherapy will have an effect on mean scores of 
mindfulness, self-kindness, alexithymia, and quality of life, such that persons who 
receive chemotherapy will report lower levels of mindfulness, self-kindness, and quality 
of life, and higher levels of alexithymia), an ANOVA will be used to determine if type of 
surgery and adjuvant therapy has main effects on mindfulness, alexithymia, self-
kindness, and quality of life.  To test Hypothesis 4 (The hypothesized path model 
specifying a relationship between mindfulness and quality of life mediated by 
alexithymia and self-kindness will account for a statistically significant amount of 
variance for quality of life), a Causal Steps Analysis with follow-up Bootstrapping will 
be used.  For further details on the hypotheses and analyses, see Table 1. 
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Table 1 
 
Hypotheses, Variables, and Data Analysis 
 
Hypothesis IV DV Analysis 
Hypothesis 1a: Time since completion of treatment will have an 
effect on quality of life, such that those further out from time since 
completion of treatment will report higher quality of life. 
 
Hypothesis 1b: Mindfulness will be positively related to self-
kindness and quality of life. 
 
 
Hypothesis 1c: Alexithymia will be negatively related to 
mindfulness, self-kindness, and quality of life.   
 
Time (less than 6 months, 
between 6 months and one year, 
greater than one year) 
 
 
 
 
 
 
 
 
Quality of life 
 
 
 
Mindfulness, 
Self-kindness, 
Quality of life 
 
Alexithymia, 
Mindfulness, Self-kindness, 
Quality of life 
 
ANOVA 
 
 
 
Pearson Product-
Moment Correlation 
 
 
Pearson Product-
Moment Correlation 
Hypothesis 2: Cancer stage will have main effects on all study 
variables, such that persons with higher stages of cancer will report 
lower levels of mindfulness, self-kindness, and quality of life, and 
higher levels of alexithymia. 
 
Cancer stage 
(0-III) 
Quality of life, 
Mindfulness, 
Alexithymia, 
Self-kindness 
ANOVA 
Hypothesis 3a: Type of surgery will have a main effect on all study 
variables, such that persons who experience more invasive surgery 
will report lower levels of mindfulness, self-kindness, and quality of 
life, and a higher level of alexithymia. 
 
Hypothesis 3b: Chemotherapy will have an effect on mean scores of 
mindfulness, self-kindness, alexithymia, and quality of life. 
 
Surgery (none, lumpectomy, 
mastectomy)  
 
 
 
Adjuvant therapy (none, 
hormone therapy, radiation, and 
chemotherapy) 
 
Quality of life, Mindfulness, 
Alexithymia, Self-kindness 
 
 
 
Quality of life, Mindfulness, 
Alexithymia, Self-kindness 
ANOVA 
 
 
 
 
ANOVA 
Hypothesis 4: The hypothesized path model specifying a relationship 
between mindfulness and quality of life mediated by alexithymia and 
self-kindness will account for a statistically significant amount of 
variance for quality of life.   
Mindfulness (predictor) 
 
Alexithymia (mediator) 
 
Self-kindness (mediator) 
 
Quality of life (criterion) Causal Steps Analysis 
with follow-up 
Bootstrapping 
Analysis 
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Pilot Study 
The primary purpose of the pilot study was to test procedures for feasibility and 
clarity and to insure research integrity for the larger study.  The first research question of 
the full study was analyzed using pilot study data in order to test data analysis procedures 
and create and test the database to be used for the full study. 
Participants 
The pilot study sample included 7 female survivors of Stages 0 to III breast cancer 
who had completed surgery and adjuvant therapy within the past two years.  Over half of 
the sample had received a lumpectomy and the entire sample received adjuvant therapy 
that included chemotherapy and radiation.  Further, over half of the sample was still 
receiving hormone therapy when they completed the assessments.  The mean age of the 
sample was 51.3 and all of the women from the sample were recruited from a cancer 
survivor wellness group.  Additional demographic data can be found in Table 1 of 
Appendix C. 
Instruments  
 Participants completed web-based surveys that included a demographic 
questionnaire, the Functional Assessment of Cancer Therapy-Breast (FACT-B; Brady et 
al., 1997), the 20-item Toronto Alexithymia Scale (TAS-20; Bagby, Parker, et al., 1994; 
Bagby, Taylor, et al., 1994) the Five Facet Mindfulness Questionnaire (FFMQ; Baer et 
al., 2006), and the Self-Compassion Scale (SCS; Neff, 2003).  Additionally, participants 
were asked to provide open-ended feedback on the procedures, including how long they 
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spent completing the surveys and what type of general feedback they had about their 
experience completing the surveys. 
Quality of life was measured using the FACT-B.  The FACT-B is a 44-item self-
report instrument with a 5-point Likert-type scale ranging from 0 (not at all) to 4 (very 
much).  The FACT-B has six subscales that include physical well-being (e.g., “I have a 
lack of energy”), social/family well-being (e.g., “I get emotional support from my 
family”), relationship with doctor (e.g., “My doctor is available to answer my 
questions”), emotional well-being (e.g., “I feel sad”), functional well-being (e.g., “I am 
able to work”), and additional concerns as they relate to breast cancer (e.g., “I feel 
sexually unattractive”).  The FACT-B was normed on two samples of women with breast 
cancer.  Internal consistency for the six subscales ranged from 0.63 to 0.86 and the alpha 
coefficient for the overall score for quality of life was 0.90.  Acceptable support was 
provided for three and seven day test-retest reliability (.88 for breast cancer scale and .85 
for total score).  Construct validity was evidenced through strong, positive correlations 
with another quality of life measure (r = .86, p < .001) and expected negative correlations 
for a mood assessment (r = -.70, p < .001; r = -.66, p < .001) (Brady et al., 1997).   
 The TAS-20 was used to measure alexithymia.  The TAS-20 is a 20-item 
instrument with three scales related to alexithymia: (a) difficulty identifying feelings 
(e.g., “I am often confused about what emotion I am feeling”), (b) difficulty describing 
feelings (e.g., “It is difficult for me to find the right words for my feelings”), and (c) 
externally oriented thinking (e.g., “I prefer to analyze problems rather than just describe 
them”).  All items are measured on a 5-point Likert-type scale ranging from 1 (not at all 
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like me) to 5 (completely like me).  Total scores can range from 20 to 100.  Higher scores 
are equated with higher levels of alexithymia (i.e., difficulty expressing emotions).  The 
TAS-20 was normed on samples of male and female university undergraduate students 
(mean age was 21.1) and male and female psychiatric out-patients (mean age was 36.62) 
(Bagby, Parker, et al., 1994; Bagby, Taylor, et al., 1994).  Bagby, Parker, et al. (1994) 
reported a Cronbach’s alpha of 0.81 for the total score, indicated acceptable internal 
consistency.  Bagby, Taylor, et al. (1994) also reported acceptable three week test-retest 
reliability (0.77, p < 0.01).  Validity was obtained by administering the TAS-20 and four 
additional assessments of psychological mindedness, need for cognition, psychosomatics, 
and a personality inventory to undergraduate students and clients from a metropolitan 
outpatient clinic (Bagby, Taylor, et al., 1994).  The TAS-20 had a strong, negative 
correlation with psychological mindedness, need for cognition, positive emotions, and 
assertiveness.  The TAS-20 also had strong, positive correlations with depression, 
anxiety, and self-consciousness (Bagby, Taylor, et al., 1994).   
 The FFMQ was used to measure mindfulness.  The FFMQ is a 39-item self-report 
instrument that measures five facets of mindfulness: (a) observing, (b) describing, (c) 
acting with awareness, (d) nonjudging, and (e) nonreacting.  Observing is defined as the 
level at which one notices internal and external sensations and stimuli (e.g., “When I take 
a shower or a bath I stay alert to the sensations of water on my body”).  Describing is 
defined as the level at which one is able to describe their observations (e.g., “I am good at 
finding the words to describe my feelings”).  Acting with awareness is defined as the 
level at which one is in the present moment and paying attention to one’s activity and 
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experiences (e.g., “I find it difficult to stay focused on what’s happening in the present”).  
Nonjudging is defined as the level at which one avoids evaluating one’s experiences and 
observations (e.g., “I criticize myself for having irrational or inappropriate emotions”).  
Nonreacting is defined as the level at which one is able to notice internal and external 
observations without reacting to them (e.g., “I perceive my feelings and emotions without 
having to react to them”).  The FFMQ is measured using a 5-point Likert-type scale 
ranging from 1 (never or very rarely true) to 5 (very often or always true).  The FFMQ 
provides a global score for mindfulness and individual subscale scores.  A sample of 
male and female undergraduate students was used to norm the FFMQ (Baer et al., 2006).  
The instrument was found to measure distinct aspects of mindfulness.  An exploratory 
factor analysis indicated that the five-factor model accounted for 33% of the variance and 
was a good fit.  Confirmatory factory analysis further concluded that the model was a 
good fit.  The FFMQ has been reported to have strong internal consistency with 
Cronbach’s alpha of .75 for nonreactivity, .83 for observing, .87 for acting with 
awareness, .91 for describing, .87 for nonjudging, and .96 for the full scale score (Baer et 
al., 2006). 
The self-kindness subscale of the SCS was used to measure self-kindness.  The 
SCS is a 26-item instrument with six subscales: self-kindness (e.g., “When I’m going 
through a very hard time, I give myself the caring and tenderness I need”) versus self-
judgment (“When I see aspects of myself that I don’t like, I get down on myself”), 
common humanity (“When I feel inadequate in some way, I try to remind myself that 
feelings of inadequacy are shared by most people”) versus isolation (“When I fail at 
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something that’s important to me I tend to feel alone in my failure”), and mindfulness 
(“When something upsets me I try to keep my emotions in balance”) versus over-
identification (“When I fail at something important to me I become consumed by feelings 
of inadequacy”).  The SCS was normed on samples of male and female undergraduate 
students and male and female practicing Buddhists.  Acceptable internal consistency has 
been reported for all subscales, with the self-kindness subscale having a reported alpha of 
.77 (Neff, 2003).  Construct validity was obtained through significant correlations with 
self-criticism (r = -.65, p < .01), social connectedness (r = .41, p < .01), depression (r =  
-.51, p < .01), and anxiety (r = -.65, p < .01) scales (Neff, 2003).  The SCS demonstrated 
acceptable three week test-retest reliability for the self-kindness subscale (.88).  For the 
purpose of this study, the unit of analysis will be the self-kindness subscale score. 
A demographic questionnaire was created by the researcher to collect relevant 
information including: age, stage of breast cancer, date of last adjuvant treatment, type of 
adjuvant treatment received, date of last surgical treatment, and type of surgical treatment 
received. 
Procedures 
 An online survey was constructed using Survey Monkey software.  Permission to 
perform the pilot study was requested and approved by the University of North Carolina 
at Greensboro’s Institutional Review Board.  After approval was obtained, a recruitment 
email was sent to members of a cancer survivor wellness group.  The members of the 
cancer survivor wellness group were selected from the same group; however, only ten of 
the 14 members of the group were selected to receive recruitment emails.  Participants 
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were selected to participate based on the availability of an email address.  The 
recruitment email included a link to the web-based surveys and information about an 
incentive to participate.  The incentive to participate included two $25 Target gift cards.  
Informed consent was provided and obtained by requesting participants to click a button 
to agree to participate in the study in order to proceed to the pilot study.  Participants who 
wished to be included in the incentive drawing were asked to provide their mailing 
address.  The surveys took 18 to 30 minutes to complete.  Data were uploaded from 
Survey Monkey into an Excel spreadsheet and then uploaded again into an SPSS (SPSS, 
2010) database.  Although the pilot study sample size was inadequate for meaningful 
analyses and conclusion, the results of the first question are reported in Appendix C.  
Research questions 2, 3, and 4 were not analyzed due to small sample size. 
 Although it is not possible to draw any conclusions from these findings because it 
is based on a sample of only 7 participants, there were a number of interesting findings 
that bear further exploration in the full study.  First of all, the field testing of procedures 
and processes was quite successful.  Participants seem to have no trouble navigating the 
online survey and indicated that the format and questions were clear.  One participant did 
indicate that it was possible to have both a lumpectomy and a mastectomy.  Accordingly, 
the Demographic Questionnaire was changed to add a response of “Both” to the question, 
“What type of surgery did you have?”  Because one potential participant began the 
survey process but did not complete the surveys, it is possible that burnout or fatigue may 
be a consideration for the full study.   
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 Of particular interest in the results was the strong correlation between 
Mindfulness and Quality of Life (r = .75).  Although it is impossible to generalize from 
such a small sample, this does provide some preliminary evidence that the primary 
predictor and criterion variables in this study do indeed have a substantive relationship.  
Of the two potential mediating variables (Alexithymia and Self-kindness), Self-kindness 
in particular bears further attention as it correlates moderately with the predictor variable 
(Mindfulness; r = .55) and strongly with the outcome variable (Quality of Life; r = .92).  
Thus, although more data is needed to afford the luxury of generalizations with any 
confidence, it appears that Self-Kindness, as hypothesized, may serve to mediate the 
relationship between Mindfulness and Quality of Life.  Whether this mediating path is 
more substantive than the direct path (i.e., how Mindfulness impacts Quality of Life 
directly) will be an interesting question for the full study. 
Revisions to Full Study Based on Pilot Study 
 Overall, the field-testing process was highly successful and there is only one 
change to the instrumentation that was made for the full study.  On the Demographic 
Questionnaire, the question, “What type of surgery did you have,” will now have an 
additional answer choice as “Both” will be added for participants who had both a 
lumpectomy and a mastectomy. 
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CHAPTER IV 
 
RESULTS 
 
 
 The purpose of this study was to investigate the relationships among mindfulness, 
self-kindness, alexithymia, and quality of life in stages 0 to III breast cancer survivors.  A 
secondary purpose was to consider how type of medical treatment and time since 
completion of medical treatment affected quality of life within this group.  In this chapter, 
the results are presented.  Results include demographic data describing the sample, 
descriptive statistics, and reliability coefficients of the measures used.  Results of the 
analyses used to test each hypothesis also are presented.   
Description of Sample 
Participants were recruited from three primary sources.  The first source included 
Cancer Services, a nonprofit agency that provides free wellness services to cancer 
patients and survivors.  The second source included past and present members of a cancer 
survivor psycho-educational wellness group, Finding Your New Normal (FYNN), which 
is sponsored by a regional cancer center in the Southeast.  Twelve hundred breast cancer 
survivors who utilized services from Cancer Services received a mailing that included a 
recruitment advertisement for the web-based survey packet constructed using Survey 
Monkey.  Further, approximately 85 breast cancer survivors who attended a breast cancer 
survivor conference sponsored by Cancer Services received survey packets that included 
administrator instructions, consent forms, and self-addressed stamped envelopes.  Finally, 
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60 breast cancer survivors who attended FYNN also received survey packets that 
included administrator instructions, consent forms, and self-addressed stamped 
envelopes.  Six participants reported having Stage 4 breast cancer and were removed 
from the dataset.  This left a total of 133 participants.  A power analysis suggested a 
sample size of 120 was necessary for a minimum power of .80 and a moderate effect size 
of .25 (Faul et al., 2007).  This sample size was determined based on the required analysis 
for research question four, which required the largest sample size. 
Prior to beginning data analyses, missing values were replaced with average 
scores for individual participants on the given subscale.  In accordance to scale 
developer’s instructions, certain items for the FACT-B, TAS-20, FFMQ, and SCS were 
reverse coded before total scale values were computed.   
In addition to data collection from the four instruments used in the study (FACT-
B, TAS-20, FFMQ, and SCS), demographic data were collected, including age, ethnicity, 
cancer stage, and medical treatment.  Medical treatment demographics included the type 
of surgery (none, lumpectomy, or mastectomy), type of adjuvant therapy (none, radiation, 
chemotherapy, both), and use of hormone therapy.  Also, participants were asked if they 
had any mindfulness training and if they maintained a mindfulness practice. 
Demographics were calculated for the entire sample and is summarized in Table 2. 
All 133 participants were female breast cancer survivors, given that the study was 
designed to investigate this population.  The average age of participants was 59.66 (SD = 
9.45).  The majority of the participants identified as White (n = 116, 87.2%). 
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Table 2 
Demographic Description of the Full Study Sample (N = 133) 
 
 
Variable M SD n    % 
             
 
Age 59.66 9.45 126 94.7 
 
Ethnicity 
 American Indian 1 0.8 
 Asian 0    0.0 
 Black, African-American 13    9.8 
 Native Hawaiian 0    0.0 
 White 116  87.2 
 Hispanic, Latina 0    0.0 
 Multiracial 1    0.8 
 
Stage 
 0 13    9.8  
 I 58  43.6 
 II 38  28.6 
 III 15  11.3 
 Unsure/Missing 9    6.8 
 
Surgery 
 None 0    0.0 
 Lumpectomy 62  46.6 
 Mastectomy 70  52.6 
 
Adjuvant Tx 
 None 28  21.1 
 Radiation 29  21.8 
 Chemotherapy 17  12.8 
 Both 56  42.1 
 
Hormone Tx 
 Yes 60 45.1 
 No 70 52.6 
 
Time since Completion of Tx 
 Ongoing  21 15.8 
 < 6 months 27 20.3 
 6 months to 1 year 10   7.5 
 > 1 year  69 51.9 
 
Mindfulness Training 
 Yes 31 23.3 
 No 99 74.4 
 
Actively Practice Mindfulness 
 Yes 17 12.8 
 No 90 67.7 
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Smaller percentages identified as Black, African-American (n = 13, 9.8%), American 
Indian (n = 1, .8%), and Multiracial (n = 1, .8%).  Stages 0 to III breast cancer were 
included in the study, although the majority of participants indicated that they were 
diagnosed with either Stage I (n = 58, 43.6%) or Stage II (n = 38, 28.6%) breast cancer.  
Thirteen participants reported a Stage 0 diagnosis (9.8%), 15 reported Stage III (11.3), 
and 9 were unclear about their diagnosis or missing data (6.8%).  All participants had 
either a lumpectomy (n = 62, 44.6%) or a mastectomy (n = 70, 52.6%) for surgical 
treatment of their breast cancer.  Not all participants, however, received adjuvant 
therapies.  Twenty-eight participants (21.1%) received no adjuvant therapy.  Nearly half 
(n = 56, 42.1%) of all participants received both radiation and chemotherapy treatments.  
Twenty-nine (21.8%) received only radiation treatment and 17 participants (12.8%) 
received only chemotherapy treatment.  Hormone therapy was split relatively evenly with 
60 participants (45.1%) receiving hormone therapy and 70 (n = 52.6%) not receiving 
therapy.  Although the majority of the sample completed their treatment over a year ago 
(n = 69, 51.9%), 21 (15.8%) were still undergoing hormone therapy, 27 (20.3%) finished 
treatment less than six month ago, and 10 (7.5%) finished between six months and one 
year ago.  The majority of participants had no training in mindfulness (n = 99, 74.4%) or 
current practice (n = 90, 67.7%). 
Descriptive Statistics for Instrumentation 
 Means and standard deviations for the total scales of the FACT-B, TAS-20, and 
FFMQ and the self-kindness subscale of the SCS were calculated for the total sample to 
assess how much variance existed for participant responses.  Norms for the FACT-B 
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were taken from a study of nearly 400 breast cancer patients (Brady et al., 1997).  Current 
study results revealed participants had lower means scores of quality of life compared to 
the population norm.  Norms for the TAS-20 were developed using two comparison 
samples of undergraduate students and psychiatric patients (Bagby, Parker, et al., 1994).  
Results of the current study revealed that the current sample had a similar mean (M = 
54.86, SD = 11.33) to the psychiatric population (M = 54.45, SD = 13.48) more so than 
the undergraduate student population (M = 47.48, SD = 10.96).  Nearly one third of the 
current sample (28%) scored in the high alexithymia range, over one third (33%) scored 
in the moderate alexithymia range, and 64% scored in the cumulative moderate to high 
alexithymia range. 
Norms for the FFMQ were formed on four samples, including student, 
community, highly educated, and meditation populations, however norms for the total 
scale were not published by the original authors (Baer et al., 2008).  The FFMQ scores 
for the current sample (M = 135.35, SD = 19.62) were substantially higher, however, than 
the scores found by Banner (2009) for a similar sample of breast cancer survivors (M = 
113.43, SD = 17.75).  Norms for the self-kindness subscale of the SCS were developed 
on an undergraduate student population (Neff, 2003).  Interestingly, results of the current 
study revealed a similar although slightly higher mean (M = 3.46, SD = .86) than found 
among the student population (M = 3.05).  It is not possible from this data to tease out the 
disease versus age effects on self-kindness, but the difference in scores is interesting.  See 
Table 3 below for results. 
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Table 3 
 
Sample Score Ranges, Means, Standard Deviations, and Norms (N = 133) 
 
Instrument 
Possible 
Range 
Sample 
Range 
Scale 
Mean 
Scale 
SD 
Norm 
Mean 
Norm 
SD 
Functional 
Assessment of 
Cancer Therapy-
Breast 
Total Scale  
0-144 40-139 110.94 19.92 112.8 20.9 
Toronto 
Alexithymia 
Scale-20 
Total Scale  
20-100 20-86 54.86 11.33 47.48- 54.45 
10.96-
13.48 
Five Facet 
Mindfulness 
Questionnaire 
Total Scale 
39-195 94-186 135.37 19.62 113.43 17.75 
Self-Compassion 
Scale 
Self-Kindness 
Subscale 
1-5 1-5 3.46 .86 3.05 .75 
 
 Cronbach’s alphas were computed as a measure of internal consistency for the 
total scales of the FACT-B, TAS-20, and FFMQ and the self-kindness subscale of the 
SCS.  Table 4 compares the alpha coefficients of the current study with published studies.  
All alpha coefficients reached or exceeded acceptable reliability levels. 
Research Questions and Hypotheses 
 The goal of the study was to examine the relationships among mindfulness, self-
kindness, alexithymia, and quality of life in female survivors of Stages 0 to III breast 
cancer.  Therefore, four research questions and seven hypotheses were developed. 
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Table 4 
 
Instrument Scale Reliabilities 
 
Instrument # of items 
α in previous 
studies 
α in current 
study 
Functional Assessment of 
Cancer Therapy-Breast 
Total Scale  
36 .90 .90 
Toronto Alexithymia Scale  
Total Scale  20 .78-.86 .82 
Five Facet Mindfulness 
Questionnaire 
Total Scale 
39 .92 .91 
Self-Compassion Scale 
Self-Kindness Subscale 5 .78 .86 
 
 
Research Question 1/Hypotheses 1a-c 
 Research Question 1 explored the effect of time since completion of treatment on 
mindfulness, alexithymia, self-kindness, and quality of life in the full study sample.  
Hypothesis 1a suggested that a time since completion of treatment would have a 
significant effect on quality of life, with quality of life being higher for those with greater 
time since completion of treatment.  Based on a one-way ANOVA, however, there was 
no significant effect of time since completion of treatment on quality of life (F(3, 126) = 
2.55, p > .05).  Hypothesis 1a was not supported (see Table 5). 
A Pearson product-moment correlation was used to analyze whether mindfulness 
was positively related to self-kindness and quality of life (Hypothesis 1b).  As 
hypothesized, mindfulness was significantly related to self-kindness (r = .65) and quality 
of life (r = .47) at p < .01.  Similarly, a Pearson product-moment correlation was used to 
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test whether alexithymia would be negatively related to mindfulness and self-kindness, 
and quality of life (Hypothesis 1c).  All three correlations were significant at p < .01.  As 
indicated in Table 6, alexithymia was negatively correlated with mindfulness (r = -.56), 
self-kindness (r = -40), quality of life (r = -.44). 
 
Table 5 
 
One-way ANOVA for Time since Completion of Treatment 
 
 Time Since 
Completion of 
Treatment 
Group 
Means df 
Mean 
Square F Sig 
FACT-B 
Ongoing 
< 6 mo 
6 mo – 1 yr 
> 1 yr 
113.55 
101.71 
117.36 
112.39 
3 
123 
126 
996.95 
391.77 
2.55 .059 
TAS-20 
Ongoing 
< 6 mo 
6 mo – 1 yr 
> 1 yr 
52.33 
56.73 
62.60 
53.43 
3 
122 
125 
320.81 
125.91 
2.55 .059 
FFMQ 
Ongoing 
< 6 mo 
6 mo – 1 yr 
> 1 yr 
139.86 
137.11 
124.60 
135.88 
3 
117 
120 
547.577 
380.970 
1.44 .235 
SCS: 
self-
kindness 
subscale 
Ongoing 
< 6 mo 
6 mo – 1 yr 
> 1 yr 
3.74 
3.50 
2.96 
3.45 
3 
117 
120 
1.29 
.70 
1.83 .146 
  
 
82 
 
 
Similarly, a Pearson product-moment correlation was used to test whether alexithymia 
would be negatively related to mindfulness and self-kindness, and quality of life 
(Hypothesis 1c).  All three correlations were significant at p < .01.  As indicated in Table 
6, alexithymia was negatively correlated with mindfulness (r = -.56), self-kindness (r = -
40), quality of life (r = -.44). 
 
Table 6 
 
Pearson Product-Moment Correlations 
             
 
Variable QOL Alexithymia Mindfulness 
             
 
QOL — — —  
Alexithymia -.44** — —   
Mindfulness .47** -.56** —  
SK .37** -.40** .65** 
             
 
*significant at the p < 0.01 level 
SK = self-kindness 
QOL = quality of life 
 
 
Research Question 2/Hypothesis 2 
Research Question 2 examined the effect of cancer stage on quality of life, 
mindfulness, alexithymia, and self-kindness.  Table 7 presents the results of a one-way 
ANOVA used to test the hypothesis that cancer stage would have a main effect on 
mindfulness, self-kindness, alexithymia, and quality of life.  No significant results were 
found for mindfulness, self-kindness, and alexithymia.  There was, however, a significant 
effect of cancer stage on quality of life (F(4, 132) = 2.76, p < .05).  Post hoc comparisons 
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with Scheffe statistic revealed that significant mean differences existed between Stage O 
(M = 121.95) and Stage 3 (M = 98.42) breast cancer and quality of life. 
 
Table 7 
 
One-way ANOVA for Cancer Stage 
 
 Stage of 
Cancer 
Group 
Means df 
Mean 
Square F Sig 
FACT-B 0 
I 
II 
III 
121.95 
112.23 
109.53 
98.42 
4 
128 
132 
1038.49 
376.59 
2.76 .03 
TAS-20 0 
I 
II 
III 
53.08 
53.33 
56.12 
57.22 
4 
127 
131 
100.74 
129.31 
.78 .54 
FFMQ 0 
I 
II 
III 
141.15 
137.42 
135.08 
129.00 
4 
122 
126 
503.06 
381.16 
.22 .93 
SCS: self-
kindness 
subscale 
0 
I 
II 
III 
3.51 
3.45 
3.56 
3.38 
4 
121 
125 
.16 
.76 
.23 .93 
 
Research Question 3/Hypotheses 3a-b 
 Research Question 3 explored the mean differences of surgery and adjuvant 
therapy on quality of life, mindfulness, alexithymia, and self-kindness.  Two one-way 
ANOVAS were used to test whether breast cancer survivors who had mastectomies 
would report lower levels of mindfulness, self-kindness, and quality of life and higher 
levels of alexithymia (Hypothesis 3a) and whether breast cancer survivors who 
underwent chemotherapy would report mean differences in study variables (Hypothesis 
3b).  No significant results were found for surgery (see Table 8). 
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Table 8 
 
One-way ANOVA for Surgery 
 
 Type of 
Surgery 
Group 
Means df 
Mean 
Square F Sig 
FACT-B Lumpectomy 
Mastectomy 
 111.34 
 110.44 
 1 
 130 
 131 
 26.70 
 401.76 
 .07  .80 
TAS-20 Lumpectomy 
Mastectomy 
 54.15 
 55.53 
 1 
 129 
 130 
 62.44 
 129.88 
 .48  .49 
 
FFMQ Lumpectomy 
Mastectomy 
 138.02 
 132.82 
 1 
 124 
 125 
 847.53 
 382.67 
 2.22  .14 
SCS: 
self-
kindness 
subscale 
Lumpectomy 
Mastectomy 
 3.46 
 3.44 
 1 
 123 
 124 
 .02 
 .73 
 .02  .88 
 
 The omnibus ANOVA indicated a significant effect of adjuvant therapy on 
quality of life (F(1, 131) = .07, p < .05).  Post-hoc comparisons using Scheffe’s statistic 
did not indicate any significant differences in FACT-B scores based on type of adjuvant 
therapy.  See Table 9 for results. 
Research Question 4/Hypothesis 4 
 Research Question 4 asked about the relationships among mindfulness, quality of 
life, self-kindness, and alexithymia within a model that specified a relationship between 
mindfulness and quality of life mediated by self-kindness and alexithymia.  The model 
hypothesized that mindfulness would not be a significant direct predictor of quality of life 
when self-kindness and alexithymia were entered into the model as mediators. 
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Table 9 
 
One-way ANOVA for Adjuvant Treatment 
 
 Type of Adjuvant 
Treatment 
Group 
Means df 
Mean 
Square F Sig 
FACT-B None 
Radiation Only 
Chemotherapy 
Only 
Both  
117.70 
114.80 
103.12 
107.39 
3 
126 
129 
1149.28 
381.12 
3.02 .03 
TAS-20 None 
Radiation Only 
Chemotherapy 
Only 
Both 
52.47 
54.78 
56.56 
55.65 
3 
125 
128 
81.66 
132.25 
.62 .61 
FFMQ None 
Radiation Only 
Chemotherapy 
Only 
Both 
137.35 
137.96 
131.35 
134.33 
3 
120 
123 
203.12 
395.33 
.51 .67 
SCS: self-
kindness 
subscale 
None 
Radiation Only 
Chemotherapy 
Only 
Both 
3.43 
3.46 
3.35 
3.49 
3 
119 
122 
.09 
.75 
.12 .95 
 
To test hypothesis 4, a causal step path analysis (Barron & Kenny, 1986) with follow-up 
bootstrapping (Preacher & Hayes, 2008) was conducted.  See Figure 2 for the results of 
the path analysis and Table 10 for the results of the bootstrapping. 
86 
 
 
 
 
 
 
 
 
 
 
*Significant at p < .01 
 
Figure 2.  Path Analysis 
 
Table 10 
 
Path Analysis of Mediating Role of Self-Kindness and Alexthymia (N = 133) 
             
 
Variable Adj R2 β se t p 
             
 
Mindfulness to Mediators (a paths)            
 Self-Kindness .42 .03 .00 9.54 .00* 
 Alexithymia .31 -.31 .04 -7.10 .00* 
 
Direct Effect of Mediators (b paths)  
 Self-Kindness .13 1.77 2.41 .74 .46 
 Alexithymia .19 -.51 .17 -3.06 .00* 
 
Total Effect of Mindfulness on QOL (c path) 
 Mindfulness .21 .49 .08 5.89 .00* 
 
Direct Effect of Mindfulness on QOL (c' path) .27 .28 .11 2.41 .02* 
 
*p > .01 
QOL = quality of life 
 Bootstrapping 
 Causal Steps Bias Corrected 
 ab Path 95% Confidence Interval 
 
Variable  Point Estimates 
 Lower Upper Mediation 
Self-Kindness  .05    -.11  .18  no 
Alexithymia  .04     .04  .31  yes 
             
Mindfulness 
Alexithymia 
Self-Kindness 
Quality of Life 
c path  = .49* R2=.21 
c ‘ path  = .28* R2=.27 
b2 path β=-.51* 
 R2=.19 
 
b1 path β=1.77 
 R2=.13 
 
a2 path β=-.31* 
 R2=.31 
 
a1 path β=.03* 
 R2=.42 
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 The overall model accounted for 27% of the variance in quality of life.  The 
results indicated that mindfulness was found to be a significant predictor of quality of life 
based on the non-mediated direct path between mindfulness and quality of life (c path, β 
= .49), in and of itself accounting for 21% of the variance in quality of life.   
Using the causal steps method, mindfulness also was found to be a significant predictor 
of quality of life (c' path, β = .28).  Further, mindfulness predicted self-kindness (a1 path, 
β = .03, R2 = .42) and alexithymia (a2 path, β = -.31, R2 = .31).  Self-kindness, in and of 
itself, did not predict a significant amount of the variance in quality of life (b1 path, β = 
1.77, R2 = .13).  Alexithymia, however, was a significant predictor of quality of life (b2 
path, β = -.31, R2 = .19). 
The causal steps analysis demonstrated evidence of a mediating relationship 
between mindfulness and quality of life, given that the direct relationship (c path, t = 
5.89, p = .00) between mindfulness and quality of life dropped when self-kindness and 
alexithymia were added to the model (c' path, t = 2.41, p = .02).  Based on Preacher and 
Hayes (2008) follow-up bootstrapping method, the ab path for alexithymia was 
significant.  Because the cˈ path for the direct impact of mindfulness on quality of life 
also was found significant, alexithymia is considered a partial mediator in the model.   
Summary 
 Results of the study were provided in this chapter.  Descriptions of the sample, 
procedures, descriptive statistics, and reliability coefficients for each instrument also 
were provided.  All instruments were found reliable and acceptable for the study sample.  
The data analysis for each hypothesis was presented and results were discussed.  
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Mindfulness was positively related to self-kindness and quality of life and negatively 
related to alexithymia.  Alexithymia was negatively related to self-kindness and quality 
of life.  A significant difference was found for Stage 0 and Stage III breast cancer 
survivor’s quality of life.  Types of surgery and adjuvant therapy were found to have non-
significant effects on quality of life.  Alexithymia was a significant mediator for 
mindfulness as a predictor of quality of life, though self-kindness was not.  In Chapter V, 
the results for each hypothesis are discussed, limitations are provided, and implications 
for counselors and future research are presented.   
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CHAPTER V 
 
DISCUSSION 
 
 
 In Chapter IV, the results of the study investigating mindfulness, quality of life, 
alexithymia, and self-kindness in Stages 0 to III breast cancer survivors were presented.  
In this chapter, a discussion of the results is provided, limitations of the study are 
outlined, and implications for counselors and areas of future research are discussed. 
Overview of the Study 
 One in eight women in the United States will develop breast cancer over the 
course of her lifetime (ACS, 2009a).  Though incidences of breast cancer are increasing, 
so too is the survival rate (ACS, 2009a).  The current survival rate for early stage breast 
cancer ranges from 84% to 98% (ACS, 2009a).  Though survivorship is celebrated, 
painful emotional and physical outcomes can arise once treatment for cancer has ended 
(Allen et al., 2009; Broeckel et al., 1998; Burgess et al., 2005; Okuyama et al., 2000).  
These outcomes have the potential to affect breast cancer survivor’s quality of life (Allen 
et al., 2009). 
 The stage of breast cancer, type of surgery and adjuvant treatment, and time since 
completion of treatment have been found to be important factors for breast cancer 
survivors (ACS, 2009a).  Further, the variation of these factors has the potential to lower 
quality of life.  Mindfulness may be a relevant construct for improving quality of life, as 
it has been positively associated with increased psychological well-being, decreased 
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medical symptoms, and fewer stress symptoms among those with stress-related illnesses, 
anxiety, cancer, and chronic pain (Baer, 2003; Carmody & Baer, 2008).   
 Further, researchers have reported high prevalence rates for alexithymia in 
women with breast cancer (Manna et al., 2007).  Alexithymia has been found to be 
associated with lower levels of health-related quality of life in the general population 
(Mattila et al., 2009) as well as increased severity of fatigue and depression (Bodini et al., 
2008), anxiety (Banner, 2009), chronic pain (Lumley, 1997), and lower levels of social 
support, increased stress, and decreased well-being (Posse et al., 2002).  Therefore, 
assessing for alexithymia in a breast cancer survivor population may be an important 
aspect of improving quality of life. 
 Self-kindness is a positive construct that involves being gentle and kind toward 
one’s self (Neff, 2003).  Because counseling is rooted in a strength-based, developmental, 
wellness orientation (Fong, 1990; Myers, 1992; Witmer & Sweeney, 1992), it is accepted 
that positive thoughts and emotions should be nurtured for optimal well-being.  No 
previous researchers have examined self-kindness in breast cancer survivors, but it seems 
theoretically conceivable that self-kindness could increase quality of life among this 
group. 
 Accordingly, this study was developed to explore the impact among mindfulness, 
quality of life, self-kindness, and alexithymia on survivors of Stages 0 to III breast 
cancer.  Also, it was the intent of this study to explore how stage of cancer, time since 
completion of medical treatment, and type of surgery and adjuvant treatment impact 
mindfulness, quality of life, self-kindness, and alexithymia.  Breast cancer survivors from 
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a cancer services organization in the Southeast and a cancer survivor psycho-education 
group completed instruments to measure the four study variables: mindfulness, quality of 
life, alexithymia, and self-kindness.  Mindfulness was measured using the Five Factor 
Mindfulness Questionnaire (Baer et al., 2006), quality of life was measured using the 
Functional Assessment of Cancer Therapy-Breast (Brady et al., 1997), alexithymia was 
measured using the Twenty-Item Toronto Alexithymia Scale (Bagby, Parker, et al., 1994; 
Bagby, Taylor, et al., 1994), and self-kindness was measured using the self-kindness 
subscale of the Self-Compassion Scale (Neff, 2003).  One hundred and thirty-three 
participants completed the instruments and a demographic questionnaire. 
 Overall, results of the statistical analyses revealed the expected relationships 
among mindfulness, quality of life, alexithymia, and self-kindness.  However, time since 
completion of treatment had no effect on the study variables.  Cancer stage had a 
significant effect on quality of life but no other study variables.  Type of surgery and 
adjuvant therapy had no effect on study variables.  The analyses provided support for the 
hypothesized path model that mindfulness is a predictor of quality of life, and 
alexithymia was found to be a partial mediator of the relationship between mindfulness 
and quality of life.  The results of each hypothesis are discussed below. 
Discussion of Results 
Hypotheses 1a-c 
 Hypothesis 1a suggested that time since completion of treatment would have an 
effect on quality of life.  The results did not support hypothesis 1a, as time since 
completion of treatment had no significant impact on quality of life (F(3, 126) = 2.55, p > 
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.05).  There are several ways to interpret this finding.  First, 15.8% of the sampled 
reported they were receiving ongoing hormone therapy.  For the purposes of this study, 
participants still taking hormone therapy were considered done with active treatment 
because many women with early stage breast cancer are prescribed to take hormone 
therapy following the completion of treatment to prevent new cancer cells from forming 
(National Cancer Institute [NCI], 2010).  For example, Tamoxifen is a common 
antiestrogen drug prescribed to women with ductal carcinoma in situ (abnormal cell 
growth in the breast ducts) (NCI, 2010).  Generally, Tamoxifen is prescribed for 2 to 3 
years and up to five years.  Tamoxifen has serious possible side effects that include 
stroke, blood clots, and uterine cancer, although more typical side effects include vaginal 
discharge, hot flashes, fatigue, nausea/vomiting, headaches, vaginal dryness, and 
irritation of the skin around the vagina (NCI, 2010).  The possible side effects of taking 
hormone therapy could have impacted the effect of time since completion of treatment on 
quality of life in such a way that the expected improvement in quality of life for survivors 
a year or more out from active treatment was confounded.  Another possible explanation 
for this result is that the developmental stage for emotional and physical transition into 
survivorship extends past the one year mark for completion of treatment.  Allen et al. 
(2009) investigated the transition from breast cancer patient to survivor in women who 
had completed treatment in the prior 12 months and found that women reported 
significant levels of emotional and physical distress.  Though time since completion of 
treatment had no significant effect on quality of life in this study it is possible that the 
categories of time since completion of treatment were too close together (i.e., under 6 
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months, 6 months to a year, and over a year).  Perhaps, time since completion of 
treatment would have had a more powerful effect on quality of life if the categories had 
been extended to specific time intervals past 12 months.  For example, would there be a 
significant effect of time since completion of treatment on quality of life for women who 
completed treatment in the past 6 months compared to 2.5 years out?  
 Hypothesis 1b suggested that mindfulness would be positively related to quality 
of life and self-kindness.  The results supported this hypothesis, in that mindfulness had a 
significant positive relationship with quality of life (r = .47, p < .01) and self-kindness (r 
= .65, p < .01).  Previous studies have found similar results for the relationship between 
mindfulness and quality of life in active breast cancer patients and newly diagnosed 
breast cancer patients (Carlson et al., 2004; Witek-Janusek et al., 2008).  This study 
confirms that mindfulness is an important factor for quality of life in breast cancer 
survivors.  One possible explanation for this finding is that breast cancer survivors who 
have an increased awareness of their own suffering may be more likely to pay attention to 
the suffering of others.  Rancour (2008) wrote that this heightened awareness for other’s 
suffering may increase positive emotions such as gratitude and understanding.  Not 
surprisingly, mindfulness also was positively related to self-kindness in breast cancer 
survivors, a positive construct.  A possible explanation for the positive relationship 
between mindfulness and self-kindness in breast cancer survivors is that women who 
have higher levels of mindfulness find it easier to be gentle and kind to themselves during 
difficult emotional and physical transitions.  As women transition away from the security 
of weekly medical appointments and lose the assurance that their health is being 
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monitored closely by capable medical staff, women mindful of their fears and grievances 
may experience a sense of universality with other breast cancer survivors going through 
similar transitions.  This connection with other survivors may elicit emotional space to be 
self-kind and self-soothing.   
 Self-kindness also was found to be significantly positively related to quality of 
life (r = .37, p < .01).  It may be that developing positive qualities, such as self-kindness, 
can serve to build personal resources and reduce intrusive negative thoughts and avoidant 
coping.  In a study of breast cancer survivors at 3, 6, 9, and 12 months post-mastectomy 
surgery, women who used avoidance at the initial baseline reported lower levels of 
quality of life 12 months post-surgery (van de Wiel, Geerts, & Hoekstra-Weebers, 2008).  
It may be that avoiding distressing thoughts and emotions contributes to lower quality of 
life.  Self-kindness involves letting go of harsh judgments and self-criticisms in favor of 
loving and gentle acceptance (Neff, 2003).  It’s possible that self-kindness could help 
breast cancer survivors embrace post-treatment thoughts and emotions.  Because limited 
research has been conducted on self-kindness, further research is needed to investigate 
further the relationship between self-kindness and quality of life. 
 Hypothesis 1c suggested that alexithymia would be negatively related to 
mindfulness, quality of life, and self-kindness.  The results supported this hypothesis.  
Alexithymia was significantly negatively related to mindfulness (r = -.56, p < .01), 
quality of life (r = -.44, p < .01), and self-kindness (r = -.40, p < .01).  These results 
suggest that being able to identify, describe, and process emotions may be related to an 
easier transition into survivorship, though it is important to reiterate that these findings 
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are correlational and causation cannot be inferred.  Fear of disease recurrence and 
heightened emotional distress are common for breast cancer survivors transitioning into 
survivorship (Allen et al., 2009).  It is possible that being able to acknowledge these 
difficult emotions may have positive outcomes related to quality of life, mindfulness, and 
self-kindness.  Previously, researchers have shown that alexithymia is associated with 
lower levels of health-related quality of life in the general population (Mattila et al., 
2009, 2010).  This study confirms this negative relationship between alexithymia and 
quality of life.  Further, previous findings suggested breast cancer survivors have a higher 
prevalence rate of alexithymia (36%; Manna et al., 2007) than the general population (5-
10%; Mattila et al., 2009); the rate of cumulative moderate to high levels of alexithymia 
for the current study was 64%.   
Hypothesis 2 
Hypothesis 2 suggested that cancer stage would have an effect on mindfulness, 
quality of life, alexithymia, and self-kindness.  Results partially supported this 
hypothesis.  There were no significant effects of cancer stage on mindfulness, 
alexithymia, and self-kindness, but a significant effect did occur for quality of life.  Post 
hoc comparisons revealed that significant mean differences existed between Stage O (M 
= 121.95, SD = 10.06) and Stage III (M = 98.42, SD = 21.34) breast cancer and quality of 
life.  Stage 0 breast cancer has a 5 year survival rate of 100% compared to 67% for Stage 
III breast cancer (ACA, 2009b).  Therefore, it is possible that survivors of Stage III breast 
cancer face increased existential concerns compared to women diagnosed with Stage 0 
breast cancer.  More specifically, a possible existential concern could relate to fear of 
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disease recurrence.  In one study, 56% of women who received curative surgical 
treatment for breast cancer reported moderate to high levels of fear of disease recurrence 
(van den Beuken-van Everdingen, Peters, Rijke, Schouten, van Kleef, & Patijn, 2008).  
Furthermore, in that study fear of disease recurrence was negatively correlated to quality 
of life.  In another study of breast cancer survivors who were on average 47 months post-
treatment, nearly one quarter (23.6%) of women reported to have moderate to high fear of 
disease progression (Mehnert, Berg, Henrich, & Herschback, 2009).  Similar to the 
previous study, fear of disease progression was significantly negatively correlated with 
quality of life.  Stage of breast cancer was found to have no effect on fear of disease 
progression, however, participants with Stage 0 were not included in this study, rather 
only Stages 1 to 1V were included.  Further research is needed to understand the internal 
process and existential concerns that may arise for breast cancer survivors, including how 
quality of life might be impacted.  Results for the impact of cancer stage on quality of life 
should be interpreted with caution, given that four analyses were run at the same time.  
Future studies replicating the results are warranted.   
Hypotheses 3a-b 
Hypothesis 3a suggested that women who had more invasive surgery 
(mastectomy) would report lower levels of mindfulness, self-kindness, and quality of life 
and higher levels of alexithymia.  This hypothesis was not supported.  A possible 
explanation for this finding is that surgery in general, regardless of the type, impacts 
quality of life, mindfulness, self-kindness, and alexithymia.  Data were not available to 
test whether having surgery versus no surgery would impact the four study variables, as 
97 
 
 
all 133 participants had surgery.  It is feasible to hypothesize that any breast 
disfigurement is traumatic and has the potential to impact the study variables.  Still, this 
was a surprising finding based on the current literature.  Skrzypulec, Tobor, Drosdzol, 
and Nowosielski (2009) found that women who experienced more invasive surgery (i.e., 
total mastectomy versus partial mastectomy) reported that the intensity of post-traumatic 
stress after the operation had a stronger impact on anxiety and depression for women with 
a total mastectomy versus a partial mastectomy.  A logical extrapolation from this would 
be that women who underwent a mastectomy versus a lumpectomy would experience a 
greater impact on the variables in the current study, but such was not the case.  It may be, 
however, that the type of surgery is less important.  Wronska, Stepien, and Kulik (2003) 
compared women who had mastectomies to a healthy control group and found that 
overall quality of life difference between groups was insignificant.  However, there were 
significant differences between groups related to the physical well-being and emotional 
well-being subscales of the FACT-B.  It is possible that role functioning and social 
functioning are less impacted by surgery, thereby affecting the overall findings related to 
quality of life.   
Hypothesis 3b suggested that chemotherapy would have more of a deleterious 
impact on mindfulness, quality of life, self-kindness, and alexithymia than radiation.  
Results indicated that the type of adjuvant therapy had a significant impact on quality of 
life, but the differences were not distinguishable in post hoc analyses.  One possible 
explanation for this is that small differences occurred across groups that provided power 
to the analysis but not enough to be distinguished in post hoc analyses.  There were no 
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significant results for mindfulness, self-kindness, and alexithymia.  Further research is 
needed to distinguish the impact of adjuvant therapy on quality of life.  Chemotherapy 
has many late onset side-effects such as neuropathy, early-onset menopause, fatigue, and 
memory problems (“chemo brain”) that have the potential to impact quality of life (ACA, 
2009a).  Because results were significant for the impact of adjuvant therapy on quality of 
life, future studies are warranted to flush out exactly what type of adjuvant therapy 
impacts quality of life. 
Hypothesis 4 
 Hypothesis 4 suggested a model specifying a relationship between mindfulness 
and quality of life mediated by alexithymia and self-kindness would account for a 
statistically significant amount of variance for quality of life.  Results indicated that the 
model was significant, accounting for 27% of the variance in quality of life.  Consistent 
with the findings of previous researchers (Carlson et al., 2004; Witek-Janusek et al., 
2008), mindfulness was a strong predictor of quality of life, in and of itself accounting for 
21% of the variance.  Although this information is correlational and causation cannot be 
inferred, the strength of this relationship is striking.  Additionally, alexithymia was a 
significant mediator.  Although the results indicated alexithymia was a significant 
mediator, it is more accurate to consider alexithymia a partial mediator, given that the 
direct relationship between mindfulness and quality of life was still significant when 
alexithymia was entered into the model.  In order for alexithymia to be considered a full 
mediator, the direct relationship between mindfulness and quality of life must be non-
significant.  Because alexithymia was a partial mediator for mindfulness and quality of 
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life and had a significant direct correlation to quality of life, alexithymia may be an 
important construct for breast cancer survivors and warrant additional attention both 
clinically and in research.  As was found in this study, previous researchers have found 
alexithymia to be related to a decreased quality of life (Mattila et al., 2009, 2010).  It is 
important to understand that alexithymia might have potential to further lower the direct 
impact of mindfulness on quality of life.  If mindfulness is thought of as an enhancer of 
quality of life and alexithymia is thought of as detraction from quality of life then 
alexithymic breast cancer survivors may be at risk for losing the positive impact of 
mindfulness on quality of life.  Accordingly, alexithymia seems to be an important 
attribute related to quality of life, but additional research is warranted to further tease out 
the role of alexithymia among breast cancer survivors. 
Limitations 
The results of the current study provide valuable information regarding the 
importance of mindfulness and quality of life for breast cancer survivors.  Also, this study 
provided insight into the mediating qualities of self-kindness and alexithymia.  Finally, 
the current study provided information about the importance of stage of cancer and type 
of surgery and adjuvant treatment for breast cancer survivors.  As with all research 
studies, however, limitation exist that contextualize the findings. 
 The study used web-based survey methodology, which has clear limitations.  
Surveys rely on participant self-report, which requires participants to have a sense of self-
awareness and report accurately.  Clearly, this is not always the case.  In using surveys, 
there is a risk that participants report limited awareness and accuracy, thereby increasing 
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the possibility for a stronger negative or positive bias than truly exists.  Further, web-
based survey methods limit the generalizability of the results, given the inherent lack of 
accurate sample description.  It is not possible to know for certain who participated in the 
study, as recruitment advertisements may have been forwarded to unknown participants.  
Also, it is not possible to know how non-respondents differ from respondents, limiting 
the external validity of the findings. 
 Another limitation of the study included measuring mindfulness and alexithymia.  
Levels of mindfulness and alexithymia could have impacted reporting.  People with 
higher levels of mindfulness may have heightened self-awareness compared to those with 
lower levels of mindfulness, which could possibly have affected how participants 
assessed their quality of life, self-kindness, and alexithymia.  The same could be said for 
alexithymia.  Participants who struggle to identity feelings and emotions may have 
underreported emotional outcomes related to quality of life. 
 This study investigated outcomes for only female breast cancer survivors.  
Though less than one percent of breast cancer survivors are male (ACA, 2009a), it is 
important to consider how the male experience of breast cancer may be different from the 
female experience.  This is especially relevant to self-kindness given the generalization 
that breast cancer is a feminine disease.   
 Another limitation involved the sampling methods.  The majority of the sample 
came from three sources, a cancer services organization in the Southeast called Cancer 
Services, a regional breast cancer survivor conference sponsored by Cancer Services, and 
a breast cancer survivor wellness group.  It is unclear how generalizable the results are to 
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other breast cancer survivors.  Further, many women from Cancer Services chose not to 
participate.  A recruitment brochure was mailed to 1200 breast cancer survivors and the 
total sample included 133 participants, which equated to a return rate of 11%.  It is 
unclear why possible participants chose to not complete the surveys.  One explanation 
could be that those who chose not to participate in the study were too fatigued or were 
experiencing more negative symptoms than those who chose to participate.  This 
explanation might indicate a possible positive bias in the results such that this sample 
may have over-reported higher quality of life.   
 A final limitation to the study included how the data were collected for the 
variable time since completion of treatment.  Participants were asked when they 
completed their final treatment in an open-ended question.  As a result, some participants 
reported the year they finished rather than the month and year.  This provided a challenge 
for data analysis.  A better way to collect this information in the future would be to have 
multiple choice options listed in months since completion of treatment.    
Implications for Counselors 
 The current study provides some empirical support for the usefulness of 
mindfulness as a quality of life intervention for breast cancer survivors.  The results 
provide evidence that breast cancer survivors with higher levels of mindfulness generally 
report higher levels of quality of life.  Although causation cannot be inferred from the 
correlational data in this study, the strength of the relationship between mindfulness and 
quality of life suggest that it may be important for counselors who work with breast 
cancer survivors to assess mindfulness and incorporate mindfulness training into their 
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counseling.  This could be done formally or informally.  Formal assessment of 
mindfulness for breast cancer survivors would include using a mindfulness assessment 
such as the Five Facet Mindfulness Questionnaire (FFMQ; Baer et al., 2006).  It is 
possible, however, to informally assess for mindfulness as well.  Informal assessment of 
mindfulness would include observing how breast cancer survivors attribute judgment to 
their experience with breast cancer.  For example, do they blame themselves for their 
diagnosis?  Do they berate themselves for not being able to jump back into a lifestyle that 
included working full-time and managing a household? Also, an informal assessment 
would include how attached clients are to their former pre-cancer self.  Do they accept 
that their body is different now? Do they accept that their perspective on life may be 
different now? Do they strive to return to exactly who they were and how things in life 
were for them before cancer? Further informal assessment of mindfulness would include 
assessing their level of self-care.  Do they feel a sense of hurry and time pressure? Do 
they avoid self-care opportunities (exercising, meditating, eating well) because they do 
not believe they have time for these activities? These are just some of the ways to 
informally assess mindfulness in breast cancer survivors.  Once the level of mindfulness 
has been determined, it is recommended that counselors integrate mindfulness training 
into the counseling process to increase quality of life among cancer survivors.   
 The results of this study also demonstrated a positive relationship between 
mindfulness and self-kindness.  A possible implication for counselors includes using 
mindfulness interventions (e.g., mindfulness training, yoga, meditation) to increase self-
kindness in breast cancer survivors.  Mindfulness and self-kindness have been found to 
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be important components related to understanding, appreciating, and being touched by 
one’s suffering (Neff, 2003).  It is feasible that increased mindfulness and self-kindness 
may be important factors in helping breast cancer survivors fully experience and accept 
their journey with cancer. 
 Another implication to the study involves the relationship between self-kindness 
and quality of life.  Until this point, self-kindness was theoretically associated with 
happiness, peace, and life enhancement (Germer, 2009).  Results from this study support 
a significant positive bivariate relationship between self-kindness and quality of life.  
Therefore, it is recommended that counselors work to foster and encourage self-kindness 
in breast cancer survivors as a way to increase their quality of life and support them 
through the difficult transition from patient to survivor.  Interventions might include (a) 
helping survivors give themselves permission to still not feel well, although treatment has 
ended, (b) helping survivors to elicit support from loved ones who expect them to be back 
to normal, (c) helping survivors to accept the parts of themselves that they do not like, 
and (d) helping survivors to identify parts of themselves they enjoy and appreciate. 
 Results from this study implied that alexithymia plays a key role via an inverse 
relationship to quality of life, mindfulness, and self-kindness among breast cancer 
survivors.  Because alexithymia is a form of emotional restriction, these findings further 
imply that it is important to be able to identify emotions, describe and express emotions, 
and accept contact with emotions for breast cancer survivors.  Though it is important to 
remember that the results are correlational, not causal, struggling with emotional 
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expression is related to decreased quality of life.  This implies that is may be important 
for counselors to help breast cancer survivors increase emotional expression skills.   
 Improving emotional expression skills may involve elements of mindfulness.  
Having a nonjudgmental awareness of the present moment may help breast cancer 
survivors begin to learn how to identify their emotions and gain contact with their 
emotions.  Similarly, observing, noticing, and attending to sensations also may help 
survivors notice and connect with their emotions.  Therefore, it is recommended that 
counselors use mindfulness training with breast cancer survivors who struggle with 
emotional expression.  This could be done in either individual or group settings. 
 Similar to mindfulness, self-kindness also may improve emotional expression 
skills in breast cancer survivors.  Breast cancer survivors who lean toward emotional 
restriction may find it easier to express themselves if they are open to their own suffering, 
which is an essential aspect of self-kindness.  Further, releasing harsh judgments and 
viewing one’s self with a sense of gentleness and love may facilitate openness to 
experiencing unwanted emotions.  Therefore, it is recommended that counselors use 
interventions to enhance self-kindness in order to help breast cancer survivors improve 
emotional expression.  
Recommendations for Future Research 
As with any study, the current study raises certain questions that warrant 
additional research attention.  One, in particular, is the finding that mindfulness is 
strongly related to quality of life.  Researchers have begun to examine the impact of 
mindfulness training on cancer survivors (Lengacher et al., 2009).  Additional research is 
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warranted to further tease out the efficacy of such programs and the mechanisms by 
which this change occurs. 
Further, the current study examined a mediating analysis for mindfulness, quality 
of life, self-kindness, and alexithymia.  Because the model was found to be significant 
but alexithymia was a partial mediator and self-kindness was not a significant mediator, a 
future study examining self-kindness and alexithymia as possible moderators may be 
warranted.  Because mindfulness significant impacted self-kindness and alexithymia, and 
alexithymia significantly impacted quality of life in the path analysis, it is clear they are 
important constructs to investigate related to quality of life.  The fact that self-kindness 
and alexithymia did not fully mediate the path between mindfulness and quality of life 
does not mean that these variables are unimportant in understanding quality of life among 
breast cancer survivors.  More research attention is warranted. 
 Results of the casual path analysis indicated that alexithymia, in particular, shows 
promise as an important factor in a multivariate consideration of breast cancer survivor 
quality of life.  The initial causal steps analysis suggested that alexithymia served a 
partial mediating function but failed to account for full mediation of mindfulness and 
quality of life.   
An additional limitation of the current study is that the sample size precluded 
examination of the individual facets of mindfulness, which have been previously 
demonstrated to be related to, but distinct from, one another (Baer et al., 2006).  Follow-
up research with a larger sample is warranted to investigate the facets of mindfulness that 
are most important for breast cancer survivors.   
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 An additional area of research that warrants attention is the role of time since 
completion of treatment.  Results from the current study were not significant; however, 
methodological limitations, including the categories of time since completion that were 
used and the lack of participants who were more further removed temporally from their 
treatment could have contributed to this finding.  Little empirical research has examined 
the developmental process from initial diagnosis, active treatment, transition into 
survivorship, and long-term survivorship.  It is reasonable to hypothesize that 
developmental transitions occur but additional empirical work is needed in this area.  
Future longitudinal studies could begin to investigate possible developmental models of 
the entire cancer experience, with a focus on survivorship stages.  As well, future short-
term research is needed to understand how survivors transition initially and long-term.    
Conclusion 
This study examined mindfulness, quality of life, self-kindness, and alexithymia 
in survivors of stages 0 to III breast cancer.  Stage of cancer, time since completions of 
treatment, and type of surgery and adjuvant therapy also were considered.  One hundred 
and thirty-three breast cancer survivors participated in this study.  Data were analyzed 
using correlations, ANOVAs, and causal path analysis with follow-up bootstrapping.  
Results supported the hypotheses that a positive relationship would exist among 
mindfulness, self-kindness, and quality of life and a negative relationship would exist 
among alexithymia and the three other study variables.  Further, results supported the 
impact of mindfulness on quality of life and suggested self-kindness and alexithymia are 
important factors to consider for breast cancer survivors.   
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Implications for counselors included (a) conducting mindfulness assessments and 
interventions to improve quality of life in breast cancer survivors, (b) helping to foster 
self-kindness in breast cancer survivors, and (c) helping breast cancer survivors process 
their emotional experience of cancer and transition into survivorship.  Additionally, it 
was recommended that counselors help improve emotional expression skills for those 
who struggle with emotional restriction. 
The current study supports further research into the moderating affects of self-
kindness and alexithymia on mindfulness, the subscales of mindfulness that are most 
relevant to breast cancer survivors, longitudinal studies on survivorship, and short-term 
studies on the initial transition into survivorship.  Using improved sampling methods and 
research designs would enhance understanding about mindfulness, quality of life, self-
kindness, and alexithymia for women who transition into breast cancer survivorship.   
There are still unknowns related to mindfulness, quality of life, self-kindness, and 
alexithymia in survivors of Stage 0 to III breast cancer.  Still, it seems clear that 
mindfulness, self-kindness, and alexithymia are important areas to explore further as 
work is done to gain knowledge about and improve the quality of life of breast cancer 
survivors navigating through a challenging transitional process. 
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Long Consent Form (Pilot Study) 
 
 
UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
 
CONSENT TO ACT AS A HUMAN PARTICIPANT: 
LONG FORM FOR PROCEDURE TESTING 
 
Project Title: Mindfulness and Quality of Life Among Breast Cancer Survivors: The 
Mediating Role of Self-Kindness and Alexithymia 
 
Project Director: Dr. Craig Cashwell, Ph.D. 
 
Participant's Name:       
 
What is the study about?  
This is a research project.  Quality of life for breast cancer survivors is an important 
consideration.  Therefore, counselors strive to create more effective interventions.  The 
goal of this study is to gain an increased understanding of the mediating characteristics of 
how mindfulness impacts quality of life in breast cancer survivors in order to inform 
clinical interventions.   
 
Why are you asking me? 
We invite you to participate in this study to help us provide information to counselors and 
counselor educators regarding the mediating affects of self-kindness and alexithymia on 
mindfulness and quality of life.  You have been selected for this survey based on your 
experience surviving breast cancer.  All participants in this study must be women over 
the age of 18 who have completed treatment for breast cancer in the last two years.   
 
What will you ask me to do if I agree to be in the study? 
This survey will take approximately 20-25 minutes to complete.  You can decide to not 
participate at any time.  If you feel discomfort at any time, feel free to stop taking the 
survey.   
 
What are the dangers to me? 
The Institutional Review Board at the University of North Carolina at Greensboro has 
determined that participation in this study poses minimal risk to participants.  However, 
there is a possibility that answering some of the questions could cause an emotional 
reaction.  If you have any emotional concerns related to filling out the questions you may 
contact Alli Forti at 617-504-2498 to schedule a counseling appointment.  Questions 
regarding your rights as a participant in this project can be answered by calling Mr.  Eric 
Allen at (336) 256-1482.  Questions regarding the research itself can be answered by Dr. 
Craig Cashwell by calling (336) 334-3427.   
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Are there any benefits to me for taking part in this research study? 
Participants may benefit from the personal satisfaction of contributing to the field of 
psycho-oncology and counselor education as this study will lead to increased information 
for the educational community of counselors and counselor educators. 
 
Will I get paid for being in the study? Will it cost me anything? 
There are no costs to you for participating in this study.  If you choose to complete the study and 
provide a mailing address, you will be entered into a drawing for a $20 gift card to Target.   
 
How will you keep my information confidential? 
All information obtained in this study is strictly confidential unless disclosure is required by law.  
Data will be stored on a password protected laptop and external hard drive.  Data will not be 
identifiable to individual participants.  Data collection procedures are anonymous.   
 
Absolute confidentiality of data provided through the Internet cannot be guaranteed due to the 
limited protections of Internet access.  Please be sure to close your browser when you finished so 
no one will be able to see what you have been doing. 
 
What if I want to leave the study? 
You have the right to refuse to participate or to withdraw at any time, without penalty.  If you do 
withdraw, it will not affect you in any way.   
 
What about new information/changes in the study?  
If significant new information relating to the study becomes available which may relate to your 
willingness to continue to participate, this information will be provided to you. 
 
Voluntary Consent by Participant: 
By clicking on the “I Agree” button you are agreeing that you read, or it has been read to you, and 
you fully understand the contents of this document and are openly willing consent to take part in 
this study.  All of your questions concerning this study have been answered.  You are agreeing 
that you are 18 years of age or older. 
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Demographic Questionnaire 
 
 
What is your age? 
 
What is your race/ethnicity? 
 
What is your sex?  
 
When were you diagnosed with breast cancer? 
 
What breast cancer stage were you diagnosed with? 
 
Did you have surgery to treat the breast cancer? 
 
What type of surgery did you have? 
 
Did you have radiation to treat your breast cancer? 
 
Did you have chemotherapy to treat your breast cancer? 
 
Did you receive hormone therapy to treat your breast cancer? 
 
When was your last treatment for breast cancer? 
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Cancer Services Questions 
 
 
Circle the number that corresponds with how much you agree or disagree with the 
following statements.  Give only once answer for each statement. 
 
Circle 0 if you STRONGLY DISAGREE 
Circle 1 if you MODERATELY DISAGREE 
Circle 2 if you NEITHER AGREE NOR DISAGREE 
Circle 3 if you MODERATELY AGREE 
Circle 4 if you STRONGLY AGREE 
 
I’m concerned about accessing the medical care I need: 
 
0     1     2     3      4 
 
I worry about the effect of stress on my diagnosis: 
 
0   1     2     3      4 
 
I worry about the change in my appearance as a result of my treatment: 
 
0     1     2     3      4 
 
I’m concerned about how I’m coping with my diagnosis: 
 
0     1     2     3      4 
 
I’m worried about how to effectively communicate with friends and family about my 
diagnosis: 
 
0     1     2     3      4 
 
I’m bothered by side effects of treatment: 
 
0     1     2     3      4 
 
I understand my diagnosis: 
 
0     1     2     3      4 
 
Answer YES or NO for the following questions. 
 
Cancer Services was able to meet my needs.  YES or NO 
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If Cancer Services had not been available to me, I know of other resources that would’ve 
been able to help me.  YES or NO 
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FACT-B 
 
Below is a list of statements that other people with your illness have said are important.  
Please circle or mark one number per line to indicate your response as it applies to 
the past 7 days. 
 
0=Not at all 
1=A little bit 
2=Somewhat 
3=Quite a bit 
4=Very much 
SOCIAL/FAMILY WELL-BEING 
 
PHYSICAL WELL-BEING 
 
     
1.  I have a lack of energy .............................................   0 1 2 3 4 
2.  I have nausea ............................................................   0 1 2 3 4 
3.  Because of my physical condition, I have trouble 
meeting the needs of my family ....................................   
 
0 
 
1 
 
2 
 
3 
 
4 
4.  I have pain ................................................................   0 1 2 3 4 
5.  I am bothered by side effects of treatment ...............   0 1 2 3 4 
6.  I feel ill .....................................................................   0 1 2 3 4 
7.  I am forced to spend time in bed ..............................   0 1 2 3 4 
 
 8.  I feel close to my friends ..........................................   0 1 2 3 4 
9.  I get emotional support from my family ..................   0 1 2 3 4 
10.  I get support from my friends .................................   0 1 2 3 4 
11.  My family has accepted my illness ........................   0 1 2 3 4 
12.  I am satisfied with family communication about 
my illness ......................................................................   
 
0 
 
1 
 
2 
 
3 
 
4 
13.  I feel close to my partner (or the person who is 
my main support) ..........................................................   
 
0 
 
1 
 
2 
 
3 
 
4 
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EMOTIONAL WELL-BEING 
 
15.  I feel sad .................................................................   0 1 2 3 4 
16.  I am satisfied with how I am coping with my 
illness ............................................................................   0 1 2 3 4 
17.  I am losing hope in the fight against my illness .....   0 1 2 3 4 
18.  I feel nervous ..........................................................   0 1 2 3 4 
19.  I worry about dying ................................................   0 1 2 3 4 
20.  I worry that my condition will get worse ...............   0 1 2 3 4 
 
FUNCTIONAL WELL-BEING 
21.  I am able to work (include work at home) .............   0 1 2 3 4 
22.  My work (include work at home) is fulfilling ........   0 1 2 3 4 
23.  I am able to enjoy life .............................................   0 1 2 3 4 
24.  I have accepted my illness ......................................   0 1 2 3 4 
25.  I am sleeping well ..................................................   0 1 2 3 4 
26.  I am enjoying the things I usually do for fun .........   0 1 2 3 4 
27.  I am content with the quality of my life right 
now ................................................................................   
    
0 1 2 3 4 
 
ADDITIONAL CONCERNS  
 
28.  I have been short of breath .....................................   0 1 2 3 4 
29.  I am self-conscious about the way I dress ..............   0 1 2 3 4 
30.  One or both of my arms are swollen or tender .......   0 1 2 3 4 
Regardless of your current level of sexual activity, 
please answer the following question.  If you 
prefer not to answer it, please mark this box           
and go to the next section. 
     
14.  I am satisfied with my sex life................................   
 
 
 
 
 
 
 
 
 
 
 
0 
 
1 2 3 4 
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31.  I feel sexually attractive .........................................   0 1 2 3 4 
32.  I am bothered by hair loss ......................................   0 1 2 3 4 
33.  I worry that other members of my family might 
someday get the same illness I have ..............................   
 
0 
 
1 
 
2 
 
3 
 
4 
34.  I worry about the effect of stress on my illness ......   0 1 2 3 4 
35.  I am bothered by a change in weight ......................   0 1 2 3 4 
36.  I am able to feel like a woman ...............................   0 1 2 3 4 
37.  I have certain parts of my body where I 
experience pain..............................................................   0 1 2 3 4 
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T A S – 20 
 
 
   Using the scale provided as a guide, indicate how much you agree or disagree with 
each of the following statements by circling the corresponding number.  Give only 
one answer for each statement. 
 
   Circle 1 if you STRONGLY DISAGREE 
   Circle 2 if you MODERATELY DISAGREE 
   Circle 3 if you NEITHER DISAGREE NOR AGREE 
   Circle 4 if you MODERATELY AGREE 
   Circle 5 if you STRONGLY AGREE 
 
         
1. I am often confused about what emotion 1 2 3 4 5 
 I am feeling. 
 
2.    It is difficult for me to find the right words 1 2 3 4 5 
      for my feelings. 
 
3.    I have physical sensations that even  1 2 3 4 5 
     doctors don’t understand. 
 
4.    I am able to describe my feelings easily.  1 2 3 4 5 
 
5.    I prefer to analyze problems rather than 1 2 3 4 5 
      just describe them. 
 
6.    When I am upset, I don’t know if I   1 2 3 4 5 
      sad, frightened, or angry. 
 
7.    I am often puzzled by sensations in my  1 2 3 4 5 
      body. 
 
8.    I prefer to just let things happen  1 2 3 4 5 
      rather than to understand why they 
      turned out that way. 
 
9.    I have feelings that I can’t quite   1 2 3 4 5 
 identify. 
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10.  Being in touch with emotions is   1 2 3 4 5 
       essential. 
 
11.   I find it hard to describe how I feel  1 2 3 4 5 
        about people. 
 
12.   People tell me to describe my feelings  1 2 3 4 5 
        more. 
 
13.   I don’t know what’s going on inside me.  1 2 3 4 5 
 
14.   I often don’t know why I am angry.   1 2 3 4 5 
 
15.   I prefer talking to people about their  1 2 3 4 5 
       daily activities rather than their 
        feelings. 
 
16.   I prefer to watch “light” entertainment        1 2 3 4 5 
        shows rather than psychological dramas. 
 
17.   It is difficult for me to reveal my               1 2 3 4 5                            
        innermost feelings, even to close friends. 
 
18.   I can feel close to someone, even in      1 2 3 4 5 
        moments of silence. 
 
19.   I find examination of my feelings useful         1 2 3 4 5 
        in solving personal problems. 
 
20.   Looking for hidden meanings in movies or       1 2 3 4 5 
        plays distracts from their enjoyment. 
 
 
    
 
 © (Taylor, Bagby & Parker, 1992)                                                                                                                      Page 1 
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 Five Facet Mindfulness Questionnaire 
 
 
Subject number_________ 
 
Date __________ 
 
Please rate each of the following statements using the scale provided.  Write the 
number in the blank that best describes your own opinion of what is generally true 
for you. 
 
1 2 3 4 5 
never or very 
rarely true 
rarely 
true 
sometimes 
true 
often 
true 
very often or 
always true 
 
_____ 1.  When I’m walking, I deliberately notice the sensations of my body moving. 
_____ 2.  I’m good at finding words to describe my feelings. 
_____ 3.  I criticize myself for having irrational or inappropriate emotions. 
_____ 4.  I perceive my feelings and emotions without having to react to them. 
_____ 5.  When I do things, my mind wanders off and I’m easily distracted. 
_____ 6.  When I take a shower or bath, I stay alert to the sensations of water on my  
  body. 
_____ 7.  I can easily put my beliefs, opinions, and expectations into words. 
_____ 8.  I don’t pay attention to what I’m doing because I’m daydreaming, worrying, or 
  otherwise distracted. 
_____ 9.  I watch my feelings without getting lost in them. 
_____ 10.  I tell myself I shouldn’t be feeling the way I’m feeling. 
_____ 11.  I notice how foods and drinks affect my thoughts, bodily sensations, and  
  emotions. 
_____ 12.  It’s hard for me to find the words to describe what I’m thinking. 
_____ 13.  I am easily distracted. 
_____ 14.  I believe some of my thoughts are abnormal or bad and I shouldn’t think that  
  way. 
_____ 15.  I pay attention to sensations, such as the wind in my hair or sun on my face. 
_____ 16.  I have trouble thinking of the right words to express how I feel about things 
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_____ 17.  I make judgments about whether my thoughts are good or bad. 
_____ 18.  I find it difficult to stay focused on what’s happening in the present. 
_____ 19.  When I have distressing thoughts or images, I “step back” and am aware of  
  the thought or image without getting taken over by it. 
_____ 20.  I pay attention to sounds, such as clocks ticking, birds chirping, or cars  
  passing. 
_____ 21.  In difficult situations, I can pause without immediately reacting. 
_____ 22.  When I have a sensation in my body, it’s difficult for me to describe it   
  because I can’t find the right words. 
_____ 23.  It seems I am “running on automatic” without much awareness of what I’m  
  doing. 
 _____24.  When I have distressing thoughts or images, I feel calm soon after. 
_____ 25.  I tell myself that I shouldn’t be thinking the way I’m thinking. 
_____ 26.  I notice the smells and aromas of things. 
_____ 27.  Even when I’m feeling terribly upset, I can find a way to put it into words. 
_____ 28.  I rush through activities without being really attentive to them. 
_____ 29.  When I have distressing thoughts or images I am able just to notice them  
  without reacting. 
_____ 30.  I think some of my emotions are bad or inappropriate and I shouldn’t feel  
  them. 
_____ 31.  I notice visual elements in art or nature, such as colors, shapes, textures, or  
  patterns of light and shadow. 
_____ 32.  My natural tendency is to put my experiences into words. 
_____ 33.  When I have distressing thoughts or images, I just notice them and let them  
  go. 
_____ 34.  I do jobs or tasks automatically without being aware of what I’m doing. 
_____ 35.  When I have distressing thoughts or images, I judge myself as good or bad,  
  depending what the thought/image is about. 
_____ 36.  I pay attention to how my emotions affect my thoughts and behavior. 
_____ 37.  I can usually describe how I feel at the moment in considerable detail. 
_____ 38.  I find myself doing things without paying attention. 
_____ 39.  I disapprove of myself when I have irrational ideas. 
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Self-Compassion Scale 
 
 
HOW I TYPICALLY ACT TOWARDS MYSELF IN DIFFICULT TIMES 
 
Please read each statement carefully before answering.  To the left of each item, indicate 
how often you behave in the stated manner, using the following scale: 
  
  Almost                                               Almost 
   never                                                 always 
      1             2             3             4             5 
 
 
_____ 1.  I’m disapproving and judgmental about my own flaws and inadequacies. 
_____ 2.  When I’m feeling down I tend to obsess and fixate on everything that’s wrong. 
_____ 3.  When things are going badly for me, I see the difficulties as part of life that 
everyone goes through. 
_____ 4.  When I think about my inadequacies, it tends to make me feel more separate 
and cut off from the rest of the world. 
_____ 5.  I try to be loving towards myself when I’m feeling emotional pain. 
_____ 6.  When I fail at something important to me I become consumed by feelings of 
inadequacy. 
_____ 7.  When I'm down and out, I remind myself that there are lots of other people in 
the world feeling like I am. 
_____ 8.   When times are really difficult, I tend to be tough on myself. 
_____ 9.   When something upsets me I try to keep my emotions in balance.   
_____ 10. When I feel inadequate in some way, I try to remind myself that feelings of 
inadequacy are shared by most people. 
_____ 11. I’m intolerant and impatient towards those aspects of my personality I don't 
like. 
_____ 12. When I’m going through a very hard time, I give myself the caring and 
tenderness I need. 
_____ 13. When I’m feeling down, I tend to feel like most other people are probably 
happier than I am. 
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_____ 14. When something painful happens I try to take a balanced view of the situation. 
_____ 15. I try to see my failings as part of the human condition. 
_____ 16. When I see aspects of myself that I don’t like, I get down on myself. 
_____ 17. When I fail at something important to me I try to keep things in perspective. 
_____ 18. When I’m really struggling, I tend to feel like other people must be having an 
easier time of it. 
_____ 19. I’m kind to myself when I’m experiencing suffering. 
_____ 20. When something upsets me I get carried away with my feelings. 
_____ 21. I can be a bit cold-hearted towards myself when I'm experiencing suffering. 
_____ 22. When I'm feeling down I try to approach my feelings with curiosity and 
openness. 
_____ 23. I’m tolerant of my own flaws and inadequacies. 
_____ 24. When something painful happens I tend to blow the incident out of proportion. 
_____ 25. When I fail at something that's important to me, I tend to feel alone in my 
failure. 
_____ 26. I try to be understanding and patient towards those aspects of my personality I 
don’t like. 
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Pilot Study 
The primary purpose of the pilot study was to test procedures for feasibility and 
clarity and to insure research integrity for the larger study.  The first research question of 
the full study was analyzed using pilot study data in order to test data analysis procedures 
and create and test the database to be used for the full study. 
Participants 
The pilot study sample included 7 female survivors of Stages 0 to III breast cancer 
who had completed surgery and adjuvant therapy within the past two years.  Over half of 
the sample had received a lumpectomy and the entire sample received adjuvant therapy 
that included chemotherapy and radiation.  Further, over half of the sample was still 
receiving hormone therapy when they completed the assessments.  The mean age of the 
sample was 51.3 and all of the women from the sample were recruited from a cancer 
survivor wellness group.  Additional demographic data can be found in Table 1.   
Instrumentation  
 Participants completed web-based surveys that included a demographic 
questionnaire, the Functional Assessment of Cancer Therapy-Breast (FACT-B; Brady et 
al., 1997), the Twenty-Item Toronto Alexithymia Scale (TAS-20; Bagby, Parker, et al., 
1994; Bagby, Taylor, et al., 1994) the Five Facet Mindfulness Questionnaire (FFMQ; 
Baer et al., 2006), and the Self-Compassion Scale (SCS; Neff, 2003).  Additionally, 
participants were asked to provide open-ended feedback on the procedures, including 
how long they spent completing the surveys and what type of general feedback they had 
about their experience completing the surveys. 
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Quality of life was measured using the FACT-B.  The FACT-B is a 44-item self-
report instrument with a 5-point Likert-type scale ranging from 0 (not at all) to 4 (very 
much).  The FACT-B has six subscales that include physical well-being (e.g., “I have a 
lack of energy”), social/family well-being (e.g., “I get emotional support from my 
family”), relationship with doctor (e.g., “My doctor is available to answer my 
questions”), emotional well-being (e.g., “I feel sad”), functional well-being (e.g., “I am 
able to work”), and additional concerns as they relate to breast cancer (e.g., “I feel 
sexually unattractive”).  The FACT-B was normed on two samples of women with breast 
cancer.  Internal consistency for the six subscales ranged from 0.63 to 0.86 and the alpha 
coefficient for the overall score for quality of life was 0.90.  Acceptable support was 
provided for three and seven day test-retest reliability (.88 for breast cancer scale and .85 
for total score).  Construct validity was evidenced through strong, positive correlations 
with another quality of life measure (r = .86, p < .001) and expected negative correlations 
for a mood assessment (r = -.70, p < .001; r = -.66, p < .001) (Brady et al., 1997).   
 The TAS-20 was used to measure alexithymia.  The TAS-20 is a 20-item 
instrument with three scales related to alexithymia: (a) difficulty identifying feelings 
(e.g., “I am often confused about what emotion I am feeling”), (b) difficulty describing 
feelings (e.g., “It is difficult for me to find the right words for my feelings”), and (c) 
externally oriented thinking (e.g., “I prefer to analyze problems rather than just describe 
them”).  All items are measured on a 5-point Likert-type scale ranging from 1 (not at all 
like me) to 5 (completely like me).  Total scores can range from 20 to 100.  Higher scores 
are equated with higher levels of alexithymia (i.e., difficulty expressing emotions).  The 
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TAS-20 was normed on samples of male and female university undergraduate students 
(mean age was 21.1) and male and female psychiatric out-patients (mean age was 36.62) 
(Bagby, Parker, et al., 1994; Bagby, Taylor, et al., 1994).  Bagby, Parker, et al. (1994) 
reported a Cronbach’s alpha of 0.81 for the total score, indicated acceptable internal 
consistency.  Bagby, Parker, et al. (1994) also reported acceptable three week test-retest 
reliability (0.77, p < 0.01).  Validity was obtained by administering the TAS-20 and four 
additional assessments of psychological mindedness, need for cognition, psychosomatics, 
and a personality inventory to undergraduate students and clients from a metropolitan 
outpatient clinic (Bagby, Taylor, et al., 1994).  The TAS-20 had a strong, negative 
correlation with psychological mindedness, need for cognition, positive emotions, and 
assertiveness.  The TAS-20 also had strong, positive correlations with depression, 
anxiety, and self-consciousness (Bagby, Taylor, et al., 1994).   
 The FFMQ was used to measure mindfulness.  The FFMQ is a 39-item self-report 
instrument that measures five facets of mindfulness: (a) observing, (b) describing, (c) 
acting with awareness, (d) nonjudging, and (e) nonreacting.  Observing is defined as the 
level at which one notices internal and external sensations and stimuli (e.g., “When I take 
a shower or a bath I stay alert to the sensations of water on my body”).  Describing is 
defined as the level at which one is able to describe their observations (e.g., “I am good at 
finding the words to describe my feelings”).  Acting with awareness is defined as the 
level at which one is in the present moment and paying attention to one’s activity and 
experiences (e.g., “I find it difficult to stay focused on what’s happening in the present”).  
Nonjudging is defined as the level at which one avoids evaluating one’s experiences and 
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observations (e.g., “I criticize myself for having irrational or inappropriate emotions”).  
Nonreacting is defined as the level at which one is able to notice internal and external 
observations without reacting to them (e.g., “I perceive my feelings and emotions without 
having to react to them”).  The FFMQ is measured using a 5-point Likert-type scale 
ranging from 1 (never or very rarely true) to 5 (very often or always true).  The FFMQ 
provides a global score for mindfulness and individual subscale scores.  A sample of 
male and female undergraduate students was used to norm the FFMQ (Baer et al., 2006).  
The instrument was found to measure distinct aspects of mindfulness.  An exploratory 
factor analysis indicated that the five-factor model accounted for 33% of the variance and 
was a good fit.  Confirmatory factory analysis further concluded that the model was a 
good fit.  The FFMQ has been reported to have strong internal consistency with 
Cronbach’s alpha of .75 for nonreactivity, .83 for observing, .87 for acting with 
awareness, .91 for describing, .87 for nonjudging, and .96 for the full scale score (Baer et 
al., 2006). 
The self-kindness subscale of the SCS was used to measure self-kindness.  The 
SCS is a 26-item instrument with six subscales: self-kindness (e.g., “When I’m going 
through a very hard time, I give myself the caring and tenderness I need”) versus self-
judgment (“When I see aspects of myself that I don’t like, I get down on myself”), 
common humanity (“When I feel inadequate in some way, I try to remind myself that 
feelings of inadequacy are shared by most people”) versus isolation (“When I fail at 
something that’s important to me I tend to feel alone in my failure”), and mindfulness 
(“When something upsets me I try to keep my emotions in balance”) versus over-
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identification (“When I fail at something important to me I become consumed by feelings 
of inadequacy”).  The SCS was normed on samples of male and female undergraduate 
students and male and female practicing Buddhists.  Acceptable internal consistency has 
been reported for all subscales, with the self-kindness subscale having a reported alpha of 
.77 (Neff, 2003).  Construct validity was obtained through significant correlations with 
self-criticism (r = -.65, p < .01), social connectedness (r = .41, p < .01), depression (r = -
.51, p < .01), and anxiety (r = -.65, p < .01) scales (Neff, 2003).  The SCS demonstrated 
acceptable three week test-retest reliability for the self-kindness subscale (.88).  For the 
purpose of this study, the unit of analysis will be the self-kindness subscale score. 
A demographic questionnaire was created by the researcher to collect relevant 
information including: age, stage of breast cancer, date of last adjuvant treatment, type of 
adjuvant treatment received, date of last surgical treatment, and type of surgical treatment 
received. 
Procedures 
 An online survey was constructed using Survey Monkey software.  Permission to 
perform the pilot study was requested and approved by the University of North Carolina 
at Greensboro’s Institutional Review Board.  After approval was obtained, a recruitment 
email was sent to members of a cancer survivor wellness group.  The members of the 
cancer survivor wellness group were selected from the same group; however, only ten of 
the 14 members of the group were selected to receive recruitment emails.  Participants 
were selected to participate based on the availability of an email address.  The 
recruitment email included a link to the web-based surveys and information about an 
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incentive to participate.  The incentive to participate included two $25 Target gift cards.  
Informed consent was provided and obtained by requesting participants to click a button 
to agree to participate in the study in order to proceed to the pilot study.  Participants who 
wished to be included in the incentive drawing were asked to provide their mailing 
address.  The surveys took 18 to 30 minutes to complete.  Data were uploaded from 
Survey Monkey into an Excel spreadsheet and then uploaded again into a SPSS (SPSS, 
2010) database.   
Data Analysis and Overview of Results 
 Although the pilot study sample size was inadequate for meaningful analyses and 
conclusion, the results of the first question are reported below.  Research questions 2, 3, 
and 4 were not analyzed due to small sample size. 
Research Question 1: What are the relationships among time since completion of 
treatment (in months), mindfulness, alexithymia, self-kindness, and quality of life for 
female survivors of breast cancer (Stages 0-III)? 
 Hypothesis 1a: Time since completion of treatment will be significantly positively 
 correlated with quality of life.   
Hypothesis 1b: Mindfulness will be significantly positively related with self-
kindness and quality of life. 
Hypothesis 1c: Alexithymia will be significantly negatively correlated with 
mindfulness,  self-kindness, and quality of life.   
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Research Question 2: What are the effects of cancer stage (0-III) on mean scores of 
mindfulness, alexithymia, self-kindness, and quality of life among female survivors of 
breast cancer?  
Hypothesis 2: Cancer stage will have main effects on all study variables, such that 
persons with higher stages of cancer will report lower levels of mindfulness, self-
kindness, and quality of life, and higher levels of alexithymia.  
Research Question 3: What are the effects of surgery (i.e., none, lumpectomy, or 
mastectomy) and adjuvant therapy (i.e., none, hormone therapy, chemotherapy, or 
radiation) on mean scores of mindfulness, alexithymia, self-kindness, and quality of life 
among female survivors of breast cancer?  
Hypothesis 3a: Type of surgery will have a main effect on all study variables, 
such that persons who experience more invasive surgery will report lower levels 
of mindfulness, self-kindness, and quality of life, and a higher level of 
alexithymia. 
Hypothesis 3b: Chemotherapy will have an effect on mean scores of mindfulness, 
self-kindness, alexithymia, and quality of life, such that persons who receive 
chemotherapy will report lower levels of mindfulness, self-kindness, and quality 
of life, and higher levels of alexithymia. 
Research Question 4: What are the relationships among mindfulness, alexithymia, self-
kindness, and quality of life within a path model that specifies a relationship between 
mindfulness and quality of life mediated by alexithymia and self-kindness? 
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Hypothesis 4: The hypothesized path model specifying a relationship between 
mindfulness and quality of life mediated by alexithymia and self-kindness will 
account for a statistically significant amount of the variance in quality of life.    
Frequencies were computed for the demographic questions.  At the time of data 
collection, two participants were receiving ongoing hormone therapy and over half 
(57.1%) had received hormone therapy as part of their adjuvant therapy.  Further, nearly 
half (42.9%) of the participants had undergone a mastectomy as part of their surgical 
treatment.  More descriptive results are reported in Table 1. 
 
Table 1 
 
Demographic Description of the Pilot Study 
 
 
Variable Mean (Range) n % 
 
 
Age 51.3 (41-56) 
 
Stage of breast Stage 0 0 0.0 
cancer Stage I 2 28.6 
 Stage II 3 42.9 
 Stage III 2 28.6 
 
Time since Ongoing (Hormone Tx) 2 28.6 
completion of < 6 months 2 28.6 
treatment 6 months to one year 1 14.3 
 > one year 2 28.6 
 
Type of surgical None 0 0.0 
treatment Lumpectomy 4 57.1 
 Mastectomy 3 42.9 
 Both 0 0.0 
 
Type of adjuvant None 0 0.0 
therapy Radiation only 0 0.0 
 Chemotherapy only 0 0.0 
 Both 7 100.0 
 
Hormone therapy Yes 4 57.1 
 No 3 42.9  
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Additionally, descriptive statistics and Chronbach alphas were calculated for each 
of the study instruments.  Albeit based on a sample size too small to make 
generalizations, results support the reliability of these instruments with the target 
population.  This information is provided in Table 2.   
 
Table 2 
 
Pilot Study Instrument Descriptive Statistics 
 
Instrument M SD α # of items 
Functional Assessment 
of Cancer Therapy-
Breast 
106.6 18 .93 37 
Twenty-Item Toronto 
Alexithymia Scale 
50.9 12.7 .87 20 
Five Facet Mindfulness 
Questionnaire 
3.3 .49 .93 39 
Self-Compassion Scale: 
Self-Kindness Subscale 
3.3 .65 .73  26 
 
*inadequate sample size 
 
  
 Hypothesis 1.  A Pearson Product-Moment Correlation Coefficient was used to 
test hypothesis 1 regarding the relationship between time since completion of treatment, 
quality of life, alexithymia, mindfulness, and self-kindness.  Self-kindness was found to 
be significantly positively correlated with quality of life (r = .92, p < .05).  Although this 
finding is inconclusive because of the small sample size, it bears attention in the full 
study.  Because these findings are based on a very small sample, the model was 
maintained for the full study.  It is possible, though, that self-kindness serves as a primary 
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predictor of quality of life rather than as a mediating variable.  No other correlations were 
significant. 
 
Table 3 
 
Pilot Study Pearson Product-Moment Correlations 
 
 
Variable  Time  QOL  Alexithymia  Mindfulness 
 
 
Time — — — — 
   
QOL -.01 — — — 
   
Alexithymia -.22 -.25 — — 
   
Mindfulness .67 .75 -.65 — 
   
SK .05 .92* .07 .55 
   
 
*significant at the p < 0.05 
 
 
Hypotheses 2-4.  Because of the limited sample size, Hypotheses 2, 3a, 3b, and 4 
were not tested.  
Discussion 
 Although it is not possible to draw any conclusions from these findings because it 
is based on a sample of only 7 participants, there were a number of interesting findings 
that bear further exploration in the full study.  First of all, the field testing of procedures 
and processes was quite successful.  Participants seem to have no trouble navigating the 
online survey and indicated that the format and questions were clear.  One participant did 
indicate that it was possible to have both a lumpectomy and a mastectomy.  Accordingly, 
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the Demographic Questionnaire was changed to add a response of “Both” to the question, 
“What type of surgery did you have?” 
 Of particular interest in the results was the strong correlation between 
Mindfulness and Quality of Life (r = .75).  Although it is impossible to generalize from 
such a small sample, this does provide some preliminary evidence that the primary 
predictor and criterion variables in this study do indeed have a substantive relationship.  
Of the two potential mediating variables (Alexithymia and Self-kindness), Self-kindness 
in particular bears further attention as it correlates moderately with the predictor variable 
(Mindfulness; r = .55) and strongly with the outcome variable (Quality of Life; r = .92).  
Thus, although more data is needed to afford the luxury of generalizations with any 
confidence, it appears that self-kindness, as hypothesized, may serve to mediate the 
relationship between Mindfulness and Quality of Life.  Whether this mediating path is 
more substantive than the direct path (i.e., how Mindfulness impacts Quality of Life 
directly) will be an interesting question for the full study. 
